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Chapter 1
Introduction: Why Do We Visualize Data
and What Is This Book About?
Restate my assumptions:
One, mathematics is the language of nature.
Two, everything around us can be represented and understood
through numbers.
Three, if you graph the numbers of any system, patterns emerge.
Sean Gullette as Maximilian Cohen in the movie  (1998).
The goal of this book is simple: We would like to show how mortality dynamics
can be visualized in the so-called Lexis diagram. To appeal to as many potential
readers as possible, we do not require any specialist knowledge. This approach
may be disappointing: Demographers may have liked more information about
the mathematical underpinnings of population dynamics on the Lexis surface as
demonstrated, for instance, by Arthur and Vaupel in 1984. Statisticians would have
probably preferred more information about the underlying smoothing methods that
were used. Epidemiologists likewise might miss discussions about the etiology of
diseases. Sociologists would have probably expected that our results were more
embedded into theoretical frameworks. . . .
We are aware of those potential shortcomings but believe that the current format
can, nevertheless, provide interesting insights into mortality dynamics, and we hope
our book can serve as a starting point to visualize data on the Lexis plane for those
who have not used those techniques yet.
Visualizing data has become increasingly popular in recent years.1 But why do
we visualize data at all? Countless books on how to visualize data — often with a
specific software tool in mind — are published every year. Maybe it seems to be too
1This trend is probably best demonstrated by visualizing the popularity of the term “visualiz-
ing data” over time, for instance, via Google’s Ngram viewer. Google Books Ngram Viewer
displays the relative frequency of a search term in a corpus of books during a given time
frame. Please see, for example: https://books.google.com/ngrams/graph?content=visualizing+
data+&year_start=1960&year_end=2008
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obvious, but only a few of those publications address the question of why one should
visualize data at all. According to the ones covering the topic, the purpose of data
visualization can be narrowed down to three reasons (e.g., Tukey 1977; Schumann
and Müller 2000; Few 2014):
1. Exploration: John Tukey stresses that exploratory data analysis “can never be
the whole story, but nothing else can serve as the foundation—as the first step”
(Tukey 1977, p. 3). He uses the expression of “graphical detective work” by
trying to uncover as many important details about the underlying data as possible.
If one explores data only with preconceived notions and theories, it is likely that
essential characteristics remain undiscovered.
2. Confirmation: It could be argued that the mere exploration of data without any
hypotheses is a misguided endeavor. Exploration needs to be firmly distinguished
from confirmatory analysis, though. While the exploration is comparable to the
work of the police, this step can be seen as the task of a judge or the jury. Both
are important to advance science, the first step is to gather the facts whereas the
second step is of judgmental nature: Can the “facts” be interpreted to support
the theory? Or do certain findings exclude some hypotheses? In this sense,
confirmatory analysis represents the core of scientific progress in Popper’s sense,
namely by falsifying theories.
3. Presentation: Presenting and communicating the findings from the data analysis
to the reader, or more appropriately, to the viewer, represents the third pillar
of why data visualization is important. Mixing up confirmatory analysis with
the presentation of the findings is probably one of the root causes for poor
scientific communication. It is a common occurrence at scientific conferences
that researchers use the same graphical tools to present their results to others as
they used to obtain their findings in the first place. As pointed out by Schumann
and Müller (2000, p. 6), this step requires careful thought that third parties are
able to understand the findings without any unnecessary difficulties.
Maps and diagrams were already known in ancient Egypt but also communicat-
ing scientific results via visualization is at least 400 years old when Galileo Galilei
(1613) and others published their observations of sunspots and other celestial bodies
(Friendly 2008). But why is data visualization only becoming increasingly popular
during the last 15–20 years? We argue that the key reason is the trend towards
virtually ubiquitous access to electronic computing resources, enabling more and
more people to participate in this endeavor. One could call it even a democratization
of computing. In our opinion we can distinguish three key developments that played
a crucial role since the 1980s and especially the 1990s. They are not listed in order
of importance nor can they be considered in isolation from each other.
Hardware: The introduction of the predecessor of all modern PCs, the IBM
personal computer, in 1981 as well as of microcomputers (e.g., the “C-64”) in the
same era triggered a shift away from the so-called minicomputers of the 1970s2 to
2As noted at https://en.wikipedia.org/wiki/Minicomputer#cite_note-Smith_1970-4 (last accessed
on 13 June 2017), the New York Times wrote in 1970 that minicomputers were computers that cost
less than US-$ 25,000.
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computers that could be purchased by households of average income. The speed
of the processors was too slow and the size of computer memory was too small
to process data as conveniently as we can nowadays, though. The first PC had
an upper limit for working memory (RAM) of 256 kB, that is about 0.000778%
of the first author’s current desktop workstation. If we disregard developments in
cache technology, parallel processing, etc., the pure clock speed of processors is
now three orders of magnitude higher than in the early 1980s. Only 20 years ago,
the typical size of total RAM was about as large as the size of a single digital
photo today. But even if there was enough RAM and sufficient clock speed of
the CPU, data storage was another limiting factor. The first hard disk with a
capacity of more than one gigabyte was introduced in 1980 and cost at least US-
$ 97,000.3 One thousand times the storage capacity is available now at less than
US-$ 100. This trend allowed the collection of massive data sets. To illustrate
current capabilities: If we were interested in creating a data set, which contains
about 1000 alphabetic characters (more than enough for the name, birth date
and current residence) of any person alive, we would have to invest less than
US-$ 400.4 But, once again, even if we had the affordable computer storage
of today, communicating results graphically was hindered by the low resolution
combined with relatively few colors of early graphics standards such as CGA and
EGA. Only with the introduction and the extension of the VGA standard, high
resolution displays have become feasible.
Software: Having hardware in terms of processing speed, working memory and
hard disk capacity to process graphics coincided with a revolution in software
in the 1990s: Similar to the introduction of home computers that gave access
to almost everyone, the emergence of free software, also called open source
software, allowed anyone to use software without the costs and other restrictions
often imposed by software products. Examples for this development can be found
in the area of
• general programming languages (e.g., Python, Perl) as well as
• languages tailored or at least particularly suited for statistical programming
and data analysis. The invention of the S language, started in the 1970s,
was instrumental.5 The most prominent example today is probably R (Ihaka
1998), but also other languages such as the now almost completely abandoned
XLISP-STAT (de Leeuw 2005) facilitate(d) the visualization of data.6
• Lastly, in the area of efficient data storage, especially with the advent of “big
data”. Although it might be one of the most abused buzzwords currently, data
3See: https://www-03.ibm.com/ibm/history/exhibits/storage/storage_3380.html, last accessed on
13 June 2017.
4Assuming a world population of less than eight billion, a price for a 2TB hard disk of less than
US-$S 100 and one byte per alphabetic letter.
5Please see Appendix A in Chambers (2008) for some notes on the history of S.
6It should be mentioned, though, that Matlab (Mathworks 2017), which is not published under a
free/open-source license, was and is also key for the analysis and visualization of data.
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sets in the gigabyte and terabyte range, partly in non-rectangular formats,
have become ubiquitous. Those data can be handled by relational and non-
relational database systems that are also available under free and open source
licenses (e.g., SQLite, MySQL, Postgresql, Cassandra).
Connectivity: While the internet existed already for more than 20 years, the
introduction and rising popularity of the world wide web (WWW) was a catalyst
for the exchange of information via electronic networks. This technology allows
now billions of people on earth to have almost instant access to data. The speed
of the internet connection, which is crucial for the exchange of information
such as downloading large data sets, has also increased by at least two orders
of magnitude since the middle of the 1990s when 56 kbit/s modems were the
standard.
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To look at 20,000 numbers and draw out their meaning
is a major research enterprise in itself.
Yet on the methods used in [Vaupel et al. (1985a)]
all that information is contained in a single contour map.
Nathan Keyfitz in his foreword of Vaupel et al. (1985a).
Any dynamics in vital events such as births and deaths involve change over calendar
time, age, and/or cohort. The so-called Lexis diagram represents the ideal canvas
to illustrate such dynamics. The Lexis Diagram as we use it today consists of a
Cartesian coordinate system where calendar time (“period”) is depicted on the x-
axis and age on the y-axis (see Fig. 2.1 on page 6).1 We added horizontal and vertical
reference lines to facilitate orientation.
Birth cohorts move in such a diagram along the 45ı line since a person is
1 year later 1 year older. Expressed differently: The current age of a person can
be calculated if we subtract the birth date from the current calendar date. We used
the example of three eminent demographers of the twentieth century in Fig. 2.1 to
illustrate this relationship: William Brass, Ansley Coale, and Nathan Keyfitz. To be
able to follow the cohorts on the 45ı line, we made sure in Fig. 2.1—as well as in
all other figures in this monograph—that the aspect ratio maps the length of one
calendar year to exactly one age year.
Of course, we are not restricted to depict individuals on the Lexis plane. The
standard approach is, indeed, to use population level data. It is obvious that we can
not draw lines for every individual in that case. Colors are used instead to indicate
the same value for the chosen statistic. While most figures in the remaining chapters
show (smoothed) age-specific mortality or its time derivative, we opted to illustrate
the basic approach of Lexis surface maps by depicting the population size of the
1It should be noted that the Lexis diagram can be considered to represent an example of “Stigler’s
law of eponymy” that states “No scientific discovery is named after its original discoverer.” Please
see Vandeschrick (2001) for a discussion about the problem of calling the diagram used in this
book a “Lexis diagram”.
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Fig. 2.1 An example of a Lexis diagram with individual life lines for William Brass, Ans-
ley J.Coale, and Nathan Keyfitz
United States for women and men combined from 1900 until 2010 for ages 0–110
in Fig. 2.2. Thus, we have 111  111 D 12;321 individual datapoints. They are less
than the 20,000 mentioned by Keyfitz in Vaupel et al. (1985a) but considerably more
than the median number of entries in data matrices for statistical graphics found by
Tufte (2003) in various scientific and non-scientific publications. Tufte—who was
described as the “da Vinci of Data” by The New York Times (Deborah 1998)—
states in a related book (Tufte 2001, p. 166): “Data graphics should often be based
on large rather than small data matrices and have a high rather low data density.
More information is better than less information, especially when the marginal costs
of handling and interpreting additional information are low, as they are for most
graphics.”
In our Lexis maps we employed a color scheme reminiscent of geographic
maps where green colors indicate lower values and brown colors are used for high
“altitudes”. Analogously to standard maps, we added contour lines to emphasize
areas of equal elevation, which translates to the same number of people in our figure.


















































Fig. 2.2 An example of a Lexis surface depicting the population size of the United States by
calendar year and age (Source: Own illustration based on data from the Human Mortality Database
2017)
Depicting mortality, fertility or other population characteristics in the Lexis
diagram provides a useful framework to analyze data for the presence of age-,
period-, and cohort- (“APC”) effects. The major problem of standard statistical
approaches (e.g., regression analysis) in this area is the so-called Identification
Problem, which refers to the perfect correlation of age plus cohort equaling period.
Various methods have been introduced (e.g., constraining the parameters in a
regression setting) but “there is no magic solution” (Wilmoth 2006, p. 235).2 With
our surface maps, we suggest instead a graphical approach that can be used for
questions such as “[w]hether mortality improvements takes place by cohorts or by
periods” (Keyfitz in Vaupel et al. 1985a, p. ix).
2Please refer to this article also for a systematic overview of APC models used in demographic
research.
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Fig. 2.3 “Ideal” age-, period-, and cohort-effects on the Lexis surface
Figure 2.3 gives an overview how age-, period-, and cohort effects would ideally
look like on the Lexis surface. The same color indicates the same value in the
variable of interest (e.g., death rates). The left panel represents “pure” age effects.
That means that the only variation in the variable of interest takes place across
the age dimension, regardless of calendar year or cohort. The panel in the middle
denotes “pure” period effects, i.e., the same values are measured at all ages but
they differ along the calendar time/period dimension (“Year”). Finally, the panel
on the right illustrates how a surface map would like if (birth) cohorts alone were
driving the development in the variable of interest. The same color along the 45ı line
shows that each cohort has their own characteristic value of the variable of interest,
which does not change throughout their life course. Obviously, those are idealized
and simplified representations. We expect to find rather interactions of these three
forces than such “pure” effects. Furthermore, we should acknowledge the biggest
drawback of our method: In contrast to other methods of APC analysis, our visual
approach does not attribute any numerical value to each of those effects. Hence, one
can neither compare various effects with each other nor is it possible to conduct
significance tests that are typical of regression analyses and other standard methods
in statistics.
We are not the first to illustrate demographic phenomena in three dimensions,
i.e., either on the Lexis plane using colors to indicate the third dimension or by
wireframe plots. An interesting overview of the history of such “Frequency Surfaces
and Isofrequency Lines” is given in Caselli and Vallin (2006). They cite the example
of Luigi Perozzo’s depiction of the change in the Swedish age pyramid in 1880,
based on a diagram by Gerard Van Den Berg (1860), as one of those earliest
examples. We have reproduced Perozzo’s diagram in Fig. 2.4. About 60 years
later, Pierre Delaporte used such wireframes to depict French mortality (1938) and
contour lines for European mortality (1942).
An explicit case of using such plots to separate age-, period-, and cohort-effects
from each other can be found in Thomas Pullum’s article on US fertility published
in 1980. A few years later, the population program at the International Institute
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Fig. 2.4 Change in the Swedish age pyramid as depicted by Luigi Perozzo in 1880 (Source:
Timothy Riffe, with kind permission)
for Applied Systems Analysis (IIASA) in Laxenburg in Austria turned out to
be an incubator for advancing the display of population dynamics on the Lexis
plane in the 1980s. Vaupel, Yashin, Caselli, and others introduced colored/shaded
contour maps to depict, for example, population size, mortality, or birth rates (e.g.,
Vaupel et al. 1985a,b, 1987; Caselli et al. 1985; Gambill and Vaupel 1985). The
“democratization” effort described in the introductory chapter was also mirrored
in the late 1990s for Lexis surfaces: Kirill Andreev developed not only the user-
friendly software Lexis to analyze demographic trends in Denmark and other highly
developed countries (Vaupel et al. 1997; Andreev 2002). He also shared it freely
with anyone interested.3 Despite being a milestone for the creation of Lexis surface
3While writing his Master’s thesis, the first author of this monograph received the Lexis software
from Kirill Andreev simply via email in early 2000.
10 2 The Lexis Diagram
maps, almost no one is using it anymore. The aforementioned specialized languages
such as Matlab (Mathworks 2017) or R (R Development Core Team 2015) have
become the favorite tools nowadays along with Python (van Rossum 1995). With
the exception of the reproduction of Perozzo’s plot all figures in this monograph
were created with R as we will explain in Sect. 3.2 and in the appendix, starting on
page 161.
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3.1.1 Human Mortality Database
Most of our analyses are based on data from the Human Mortality Database
(“HMD”, 2017), which can be freely accessed after registration at http://www.
mortality.org. The database is a collaborative project of research teams from the
Department of Demography at the University of California, Berkeley (USA) and the
Max Planck Institute for Demographic Research in Rostock (Germany). It contains
aggregate mortality statistics such as death counts, population estimates, exposure
to risk estimates, life tables as well as some other statistics of more than 35 countries
(see Table 3.1). Further distinctions into sub populations are possible for some
countries such as Germany (East and West Germany), the United Kingdom (England
and Wales, Northern Ireland, Scotland) or New Zealand (Maori, Non-Maori). The
database has its focus on highly developed countries.
Since its launch in 2002, the HMD has become the gold standard for the aggre-
gate level (demographic) analysis of mortality. Apart from the diligent collection of
data, its widespread adoption can mainly be attributed to two reasons: (1) Rigorous
quality checks are conducted before new data are added to the database. (2) The
biggest asset of the HMD is that it does not simply publish processed data. Instead,
the HMD estimates life tables and other statistics itself using raw data, applying
the same set of methods. Thus, any differences over time or across region can not
be attributed to different methodologies, for instance, how the life table was closed
(HMD 2007).
As some life tables in the HMD are smoothed at ages 80 and higher, we did
not rely on life tables estimates at all but used exclusively the death counts and
the corresponding exposures from the HMD on a 1-calendar-year by 1-age-year
grid to estimate death rates. Most of our analyses deal with mortality developments
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Table 3.1 Countries covered in the Human Mortality Database and data coverage after 1950 on
January 10th, 2017, when the most recent update of data was conducted for the present monograph
since 1950. We selected this threshold year because of the availability of more data
compared to earlier time periods. Furthermore, it also marks the beginning of a
new era: Most gains in life expectancy are nowadays due to survival improvements
among the elderly (Christensen et al. 2009), a development, which was virtually
non-existent before the middle of the twentieth century. Kannisto (1994), for
instance, estimated that the onset of sustained decline in old-age mortality occurred
for women in Switzerland, Belgium and Sweden in 1956.
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As shown in Table 3.1 total deaths range from barely 100,000 (Iceland) to more
than 130 million in the United States. We analyzed all countries; the only exceptions
are Chile and the Maori population of New Zealand due to problematic data quality
(Jdanov et al. 2008) and the low number of years covered (Chile). Nevertheless, we
did not include those figures for all countries and both sexes as it would have resulted
in a monograph consisting of hundreds of additional pages. We typically restricted
ourselves, instead, to a few examples that feature interesting characteristics.
3.1.2 Cause-Specific Death Counts in the United States
The National Center for Health Statistics of the United States provides a unique
collection: Individual death counts by sex, age at death, year of death, cause of
death, and many more characteristics can be freely downloaded from its web page.
The data are available since 1968 in annual files. Additionally, the website of the
National Bureau of Economic Research (NBER) provides data since 1959, which
we used in our analyses. The last year in our analysis is 2014. With the exception of
1972, when only a 50% sample was taken, each file contains all deaths in the United
States. In the analysis by cause of death in later chapters of this volume, we simply
multiplied the number of deaths for a given age, sex, and cause in the year 1972 by
a factor of 2.
Causes of death are coded by the so-called “International Classification of
Diseases” (ICD). Since its introduction in the late nineteenth century, the system
has been revised at irregular intervals (Meslé 2006). The tenth revision is currently
used. During the first years of our analysis, ICD-7 was used. ICD-8 was in effect in
the United States between 1968 and 1978, followed by ICD-9 from 1979 until 1998.
Obtaining consistent time series of causes of death across ICD revisions requires
meticulous work and care (e.g., Meslé and Vallin 1996; Pechholdová 2009). We
therefore decided to use only very broad categories for causes of death and followed
primarily the coding of Janssen et al. (2003) and of Meslé and Vallin (2006a).
Both papers include an appendix with detailed ICD codes across the four revisions
required in our analysis.
Table 3.2 is split into two halves. The upper panel provides the ICD codes we
used to extract the causes of death, whereas the lower panel lists the number of
deaths in absolute and relative terms for the selected causes by sex.
Our database consists of more than 118 million deaths. Although we have
selected very few causes, they account for about three quarters of all deaths
(Category 13 “Other” is 23.75%). A bit more than 44% of all deaths classified
as originating from circulatory diseases. In that category, heart diseases are about
one third of all deaths for women and men alike. The almost 10 million deaths
from cerebrovascular diseases between 1959 and 2014 represent about eight percent
of all deaths. The most common cerebrovascular disease is stroke. Malignant
neoplasms (“cancer”) are the second largest chapter in the ICD. Regardless of
sex of the decedent, about one in every fifth death belongs to that category. We
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Table 3.2 ICD codes and counts (absolute and relative) for females, males, and both sexes
combined selected causes of death, 1959–2014
Cause ICD codes
ICD-7 ICD-8 ICD-9 ICD-10
Nr. Years in use: 1959–1967 1968–1978 1979–1998 1999–2014
(1) All causes — — — —
(2) Circulatory dis. 300–334, 390–458 390–459 I00–I99
400–468
(3) Heart 400–447 390–429 390–429 I00–I52
(4) Cerebrovasc. 300–334, 430–434, 430–434, I60–I69
436–438 436–438
(5) Other All (2) not in (3) or (4)
(6) Cancers 140–239 140–239 140–239 C00–D48
(7) Breast 170 174 174, 175 C50
(8) Lung 162, 163 162 162 C33, C34
(9) Colorectum 153, 154 153, 154 153, 154 C18–C21
(10) Other All (6) not in (7), (8), or (9)
(11) Resp. diseases 470–527 460–519 460–519 J00–J99
(12) Motor vehicle acc. E810–E825 E810–E819 E810–E819 V00–V89
(13) Other All (1) not in (2)–(12)
Number of cases
Total Female Male
Nr. Cause Counts % Counts % Counts %
(1) All causes 118,678,283 (100.00) 56,432,184 (100.00) 62,246,099 (100.00)
(2) Circulatory dis. 52,668,448 (44.38) 25,985,900 (46.05) 26,682,548 (42.87)
(3) Heart 40,342,012 (33.99) 19,072,073 (33.80) 21,269,939 (34.17)
(4) Cerebrovasc. 9,381,071 (7.90) 5,430,076 (9.62) 3,950,995 (6.35)
(5) Other 2,945,365 (2.48) 1,483,751 (2.63) 1,461,614 (2.35)
(6) Cancers 25,722,893 (21.67) 12,096,049 (21.43) 13,626,844 (21.89)
(7) Breast 2,067,878 (1.74) 2,050,192 (3.63) 17,686 (0.03)
(8) Lung 6,393,007 (5.39) 2,260,023 (4.00) 4,132,984 (6.64)
(9) Colorectum 2,884,519 (2.43) 1,458,772 (2.59) 1,425,747 (2.29)
(10) Other 14,377,489 (12.11) 6,327,062 (11.21) 8,050,427 (12.93)
(11) Resp. diseases 9,566,798 (8.06) 4,457,141 (7.90) 5,109,657 (8.21)
(12) Motor vehicle acc. 2,538,449 (2.14) 742,599 (1.32) 1,795,850 (2.89)
(13) Other 28,181,695 (23.75) 13,150,495 (23.30) 15,031,200 (24.15)
selected three prominent cancer sites: Breast, lung and colorectum. Please note that
while there are many more deaths from breast cancer for women, also more than
17,000 men died from it during the 56 years of our observation period. Respiratory
diseases are with approximately 8% of all deaths slightly more common than
cerebrovascular diseases. Although it is not a major cause of death (2%), we also
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included information about motor vehicle accidents since it turned out to be an
interesting case study for seasonality in deaths, which we analyze in Chap. 9.
3.1.3 SEER Cancer Register Data 1973–2011
The Surveillance, Epidemiology, and End Results (SEER) Program of the National
Cancer Institute of the United States allows researchers access to longitudinal data
on the individual level about the incidence of cancer and includes also information
about the survival of patients. The data coverage—the SEER data start in 1973—and
the large size of data, combined with the ease of access, make the SEER data an ideal
instrument for the analysis of cancer survival by age over calendar time. We were
using data that were released in April 2014 with a follow-up cutoff date of December
31, 2011 (Surveillance, Epidemiology, and End Results (SEER) Program 2014). The
SEER data do not cover all cancer diagnoses of the United States. It is a collection
of data from several registries. With the exception of Seattle (Puget Sound) and
Metropolitan Atlanta that started in 1974 and 1975, respectively, we only used
registers that covered the whole time span from 1973 until the end of 2011. Although
we use less data than we could have, we thought that a heterogeneous set of registers
would have induced problems for the analysis over time. The registers included
in our analysis were: San Francisco-Oakland SMSA, Connecticut, Metropolitan
Detroit, Hawaii, Iowa, New Mexico, Utah as well as Seattle and Metropolitan
Atlanta.
In our analysis of cancer survival in Chap. 10, starting on page 123, we selected
five cancer sites: Breast cancer; cancer of the lung and bronchus; cancer of the colon,
rectum, and anus; pancreatic cancer; prostate cancer. As shown in Table 3.3, those
five cancer sites constitute about 55% of all cancer diagnoses for women as well as
for men out of the 4.5 million cases recorded during our observation period. The
largest categories are by far breast cancer for women (30.44%) and prostate cancer
for men (25.79%). The absolute and relative frequencies of the other cancer sites as
well as their respective ICD codes can be inspected from Table 3.3. While ICD-8
was in use at the beginning of the observation period in 1973 and cancer cases are
typically coded by the ICD-O standard, all ICD codes were converted to ICD-10 by
SEER.
3.2 Software
All analyses have been conducted and all figures have been produced using R
(Version 3.2.3), a free software environment for statistical computing and graphics
(R Development Core Team 2015). The surface maps were created by the image()
function and contour lines were added with the contour() function. To facilitate
the creation of surface maps of rates of mortality improvement for other researchers,
16 3 Data and Software
Table 3.3 ICD-10 codes and incidence counts (absolute and relative) by cancer site of females,
males, and both sexes combined in the SEER Data, 1973–2011
Incidence
ICD-10 Total
Cancer site Code Counts in %
(1) All C00–D48 4;524;099 (100.00)
(2) Breast C50 713;376 (15.77)
(3) Bronchus and lung C34 557;901 (12.33)
(4) Colon, rectum, and anus C18-C21 520;456 (11.50)
(5) Pancreas C25 103;152 (2.28)
(6) Prostate C61 566;311 (12.52)
(7) Rest All (1) not in (2)–(6) 2;062;903 (45.60)
Incidence
Female Male
Cancer site Counts in % Counts in %
(1) All 2,328,116 (100.00) 2,195,983 (100.00)
(2) Breast 708,696 (30.44) 4,680 (0.21)
(3) Bronchus and lung 224,927 (9.66) 332,974 (15.16)
(4) Colon, rectum, and anus 257,406 (11.06) 263,050 (11.98)
(5) Pancreas 51,712 (2.22) 51,440 (2.34)
(6) Prostate N/A (N/A) 566,311 (25.79)
(7) Rest 1,085,375 (46.62) 977,528 (44.51)
an R package called ROMIplot has been created and uploaded to CRAN, the
general archive of R packages. Installation and usage of this package are explained
in Appendix “Software: R package ROMIplot” (p. 161).
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Chapter 4
Surface Plots of Observed Death Rates
4.1 From Death Counts to Death Rates
The basic units of any mortality analysis are death counts. In most scientific
disciplines those counts are expressed as rates by dividing them by a unit of time.
Examples are heart rates counting beats per minute or becquerel measuring the
radioactive decay of nuclei per second. Things are more complicated when death
counts are analyzed: For instance, 30,140 people died at age 80 in Germany in 2000.
The corresponding number of Austria is 2,765 (HMD, 2017). Inferring that the risk
of dying is more than ten-fold higher in Germany than in Austria is obviously wrong.
Death rates are—as all demographic rates—therefore standardized dividing the
counts by the corresponding number of life-years lived (see, for example Chap. 1.4
in Preston et al. 2001). The latter are often called “exposures” and are typically
approximated by an estimate of the mid-year population. In the example above,
the death rates at age x D 80 in year t D 2000, usually denoted as m.x; t/ would
correspond to:














with death counts and exposures denoted as D.x; t/ and N.x; t/, respectively. Hence,
mortality is still higher in Germany than in Austria but only by about three per cent
and not by an order of magnitude. Death rates at those single ages x, that are used
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exclusively in this book, are often a good approximation for the continuous force of
mortality at the middle of that age .x C 0:5/ (Thatcher et al. 1998). Nearly all of
the analyses contained in this volume are based on such death rates.
4.2 Results
The raw surface plots on the following pages depict the observed death rates for
women and men in a few selected countries. Death rates were estimated for single
ages and single years from 1950 until the last available year in the Human Mortality
Database, in most cases 2014 (see Chap. 3). Our color scheme ranges from blue
to green to red. To facilitate interpreting the plots, we added contour lines for
various levels of mortality similar to the ones for elevation on topographic maps.
The levels of 1 death per 10 person-years lived, per 100 person-years lived, per
1,000 person-years lived, and per 10,000 person-years lived have been printed as
bold lines as visual cues not because of any implicit distinct meaning apart from the
digit preference.
Generally speaking, we do not think that raw surface plots are the best option to
visualize mortality dynamics. That is why we only depict a few countries here. One
of the main problems is that the observed rates suffer from random fluctuations. At
young ages because death rates are so low; at older ages because there are so few
people left. Thus, the numerator for the observed death rates is relatively small in
the first case whereas the denominator is relatively small in the latter case.
What we can observe for Australian women and men in Figs. 4.1 and 4.2 is
representative for many countries in the Human Mortality Database1: Most contour
lines tend to move upwards over time. This indicates that the same level of mortality
is being observed at higher and higher ages. Or, expressed differently, mortality is
continuously decreasing at almost any given age. Switzerland and Spain in Figs. 4.3,
4.4, 4.5 and 4.6 are further examples of this general trend. It seems to be noteworthy
that the late 1990s seems to be an important era for major improvements in mortality
among young males.
We can already observe here the unfortunate mortality developments that took
place in Russia (Figs. 4.7–4.8) as well as in many other eastern European countries








   
   
  
      
    
  
    
  

































































































































    
  










































Fig. 4.1 “Raw” death rates for women in Australia, 1950–2011 (Data source: Human Mortality
Database)
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Fig. 4.3 “Raw” death rates for women in Spain, 1950–2014 (Data source: Human Mortality
Database)
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Fig. 4.5 “Raw” death rates for women in Switzerland, 1950–2014 (Data source: Human Mortality
Database)




      
   
 
    












    
  
    
  
  























































































    
  
      
  
    



















    
  
  




    
  
      



































































































   
   
          
  






    
  
        




































Fig. 4.7 “Raw” death rates for women in Russia, 1959–2014 (Data source: Human Mortality
Database)













































    
  
      
    
  
  






    
  
  
      
  
  
    
        
    
  




































Fig. 4.8 “Raw” death rates for men in Russia, 1959–2014 (Data source: Human Mortality
Database)
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(not shown here) that have been distinct from the rest of Europe: Irregular trends,
especially among males, and even increasing mortality as depicted by the downward
contour lines have been rather the rule than the exception between the 1960s and the
early 2000s.
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Chapter 5
Surface Plots of Smoothed Mortality Data
5.1 From Raw Death Rates to Smoothed Death Rates
We have seen in the previous chapter, that “raw” death rates can suffer from
considerable random fluctuations. Assuming that data quality is not an issue, this
noise can be caused by (1) very few numbers of deaths (numerator), by (2) very
few persons exposed to the risk of dying (denominator) or by (3) small populations
in general. Problem (1) typically occurs at young ages. We selected age 15 in
France in Panel (a) of Fig. 5.1. Despite a large population in general, deaths occur—
thankfully—relatively rarely at that age. (2) The opposite is true at advanced ages as
shown in the middle panel of the same figure. Very few people are still alive at age
95 in Italy, although it is a large population having relatively high life expectancy.
Problems (1) and (2) occur in countries with tens of millions of people only at young
and old ages. The smaller the population size, the more ages are affected. Panel (c)
illustrates issue (3) using Danish data. The mortality trajectory in highly developed
countries is rather smooth around age 80. In countries with just a few millions of
people, considerable random fluctuations can be even observed there. Please note
that more than five million people live in Denmark. Hence, the challenge becomes
even bigger in smaller countries such as the Baltic states, Luxembourg or, especially,
in Iceland.
We decided therefore to smooth the data. Myriads of methods exist to smooth
data. While the pattern over age can be appropriately captured by parametric
models, the trajectory over time differs considerably between ages and countries.
Our decision was therefore to use a non-parametric smoothing approach. We
selected the so-called P-spline approach, originally developed by Eilers and Marx
(1996), adapted to the analysis of mortality by Currie et al. (2004) and further
refined by Camarda (2008). The author, Carlo Giovanni Camarda, also provides
the R extension package “MortalitySmooth” (Camarda 2012), which makes it
easy and straightforward to apply the method. At its core, the model assumes
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c) Death Rates at Age 80 in Denmark,
Women, 1980−2010
Fig. 5.1 The necessity to smooth raw death rates. Using data for France, Italy, and Denmark,
panel (a), (b) and (c) illustrate three sources of random fluctuations: few numbers in the numerator
(Panel (a) for age 15), few numbers in the denominator (Panel (b) for age 95) or small population
sizes in general (Panel (c) for age 80) (Data source: Human Mortality Database)
Poisson distributed death counts with the (log-)exposures as an offset to account
for changing population sizes over time and/or age. The method uses B-splines
as regression bases. Whereas the number and position of the basis functions is
crucial for standard smoothing with B-splines, the P-spline approach uses “too
many” bases, which would normally result in overfitting. The P in the name of
the method refers to the penalization of adjacent regression coefficients that differ
too much from each other. Further technical details about the basis functions, the
order of the differences, the penalty term , etc. are extensively discussed in the
aforementioned references. The bold solid black lines in each panel of Fig. 5.1
depict the data smoothed with P-splines for the three given ages over time. One
can easily recognize that the selected smoothing method is flexible enough to model
irregular developments but is not prone to overfit the data.
The univariate time series of Fig. 5.1 is synthetic. Only cartoon characters such
as Bart Simpson or Eric Cartman can retain their age over time. In reality, each
individual is 1 year later 1 year older. Therefore we smoothed the data simultane-
ously over age and time using the function Mort2Dsmooth of Camarda’s package
“MortalitySmooth” (2012).
Raw death rates for Estonian women aged 60–80 years from 1980 to 2000 are
illustrated in the left panel of Fig. 5.2 as a three-dimensional mortality surface. The
general shape of increasing mortality over age can easily be observed. The right
panel, featuring smoothed data, also shows the decline in mortality at higher ages















Fig. 5.2 3D plot of raw and smoothed death rates of Estonian women aged 60–80 years in 1980–
2000 (Data source: Human Mortality Database)
The selected three-dimensional perspective plot appears appealing at first sight. The
choice of angle and elevation is somehow arbitrary, though, and allows to accentuate
certain features and suppress others. Since we often want to use the mortality surface
for exploratory purposes, we have to give equal exposure to each unit. Therefore, we
projected the three-dimensional data on the two-dimensional Lexis-plane, denoting
the level of mortality by different colors (see Fig. 5.3 as an example).
Comparable to topographic maps, we added contour lines to depict the same
levels of mortality. The general upward tendency of the contour lines indicate that
the same level of mortality is shifting to higher and higher ages. Thus, for a given
age mortality is decreasing, resulting in an increase in life expectancy.
5.2 Results
Figures 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 5.10, and 5.11 depict the same set of countries
as Figs. 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, and 4.8 in Chap. 4 for a proper comparison
between “raw” rates and smoothed rates.1 The smoothed surface maps make the
major trends in the data more pronounced such as almost parallel straight upward
1The appendix contains therefore also maps of smoothed death rates for France, England & Wales,
and Norway. They can be found in Figs. A.7, A.8, A.9, A.10, A.11, and A.12.



















Fig. 5.3 Death rates of Estonian women aged 60–80 years in 1980–2000 as an example of
smoothed death rates on the Lexis plane (Data source: Human Mortality Database)
lines in Australia, Spain, and Switzerland or the sudden survival improvements in
survival among young Spanish men, starting in about 1990. Also large random
fluctuations due to very few deaths as we have seen in the plot of raw death rates
among children in Switzerland (Figs. 4.5 and 4.6) are removed by the smoothing
procedure. While smoothing intrinsically involves some dampening of sudden





      
  












































































Fig. 5.4 Smoothed death rates for women in Australia, 1950–2011 (Data source: Human Mortality
Database)























































































       


































    



































Fig. 5.6 Smoothed death rates for women in Switzerland, 1950–2014 (Data source: Human
Mortality Database)
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Fig. 5.8 Smoothed death rates for women in Spain, 1950–2014 (Data source: Human Mortality
Database)





    
  
  
      
  
  




































    
  
  







































































    
  
  









































Fig. 5.10 Smoothed death rates for women in Russia, 1959–2014 (Data source: Human Mortality
Database)





























    
    
  
  









































Fig. 5.11 Smoothed death rates for men in Russia, 1959–2014 (Data source: Human Mortality
Database)
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feature, for instance, the mortality crises among Russian men during the 1980s and
1990s. We do not want to go into further detail here as these smoothed surface
maps serve as the major building blocks for the surface maps of rates of mortality
improvement, which are the focus of our book and are presented in the next
chapter.
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Chapter 6
Surface Plots of Rates of Mortality Improvement
6.1 From Smoothed Death Rates to Rates of Mortality
Improvement
The colors and contour lines in Fig. 5.3 suggest also a change in pace over time:
Each level of mortality seems to change its slope in the early 1990s. We argue that
those trend changes are better illustrated with “rates of mortality improvement”,
which we labeled “ROMIS”, than with (smoothed) surface maps of mortality. Given
death rates at age x in year t, m.x; t/, we defined the rates of mortality improvement,
, by assuming a constant rate of change within the period of comparison. In this
monograph, we only used annual changes. Hence:
.x; t/ D  loge

m .x; t C 1/
m .x; t/

It is simply a reformulation of the standard equation for growth with a constant
rate r: P.t/ D P.0/ert (e.g., Keyfitz 1977). The minus sign ensures to have positive
numbers for survival improvements. We expressed the respective values for  in
percent. It is comparable to Kannisto et al. (1994) who used a discrete version of the
growth equation and aggregated several ages and years.
Figure 6.1 illustrates those ROMIS again with data for Estonian women. To
provide a more comprehensive overview, we expanded the age range as well as
calendar time. No change or negligible changes (0:5%    0:5%) are depicted
in white. Slight improvements (0:5% <   2:0%) are shown in three shades of
blue, larger improvements in green colors (2:0% <   4:0%) and very strong
improvements ( > 4:0%) in red colors and yellow. If mortality increased, i.e., the
survival conditions worsened, we used darker shades of gray for larger mortality
increases. Please note that an annual change of  D 0:035 D 3:5% cuts mortality
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Fig. 6.1 Example of rates of mortality improvement on the Lexis plane: Estonian women aged 0
to 100 years in 1959–2012 (Data source: Human Mortality Database)
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in half in less than 20 years.1 But even at  D 2%, which we listed at the threshold
from moderate to strong improvements, it requires less than 35 years for a reduction
by 50%.
How can we interpret Fig. 6.1, which could be mistaken for a piece of modern art
at a first glance? The main shapes appear to be vertical. This implies that mortality
changes affected virtually all age groups at the same moment in time—classical
period effects. We can also see that white and gray are the dominant colors for
females in Estonia for the 1970s and the 1980s. Thus, mortality remained more or
less constant during those two decades. During the 1980s at ages 35–60, we can
even spot some dark gray areas that correspond to increasing levels of mortality.
We can witness a trend reversal approximately in 1990. Within a couple of years,
Estonian women at almost all ages experienced remarkable survival improvements.
The colors illustrate that mortality dropped by more than 4% for several years at
some ages. At such a rapid pace, it takes about 10 years to cut mortality by a third.
6.2 Results
Figures 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 6.10, 6.11, 6.12, 6.13, 6.14, 6.15, 6.16,
6.17, 6.18, 6.19, 6.20, and 6.21 (pages 46–65) depict Lexis diagrams of rates of
mortality improvements (“ROMIs”), which are the time derivative of age-specific
death rates. We argue that those maps are better able to illustrate mortality dynamics
than the commonly used “heat maps” of mortality. We plotted our first ROMIs on
the Lexis surface about 10 years ago (Rau et al. 2008). In the meantime, those plots
have become more commonplace, especially among actuaries, to visualize mortality
dynamics. Our method can be considered as a descriptive tool. It is able to detect
the predominant dynamics of mortality (or of any other phenomenon measured
on the Lexis surface). We think that those “ROMI”-maps provide better insights
into mortality dynamics than standard surface maps but are equally intuitively
understandable.
During the 1950s, the first years of our observation period, survival improved
tremendously especially for infants, children, and young adults. The most remark-
able declines in mortality were recorded for Japanese females (Fig. 6.14, page 58).
After the end of World War II, life expectancy in Japan was below the average of
western European countries. According to data from the Human Mortality Database,
life expectancy for Japanese females rose from 60.9 years in 1950 to 72.3 in 1963.
Thus, life expectancy increased by almost 1 year within each calendar year during
that time span! But also France (Fig. 6.9, p. 53), Italy (Fig. 6.13, p. 57), England &
Wales (Fig. 6.7, p. 51) or the United States (Fig. 6.21, p. 65), to name only a few,
gained several years of life due to mortality declines at younger ages.
10:5m.x; t/ D m.x; t/e tI 0:5 D e tI loge .0:5/ D tI loge .0:5/ =I loge .0:5/ =0:035 D
19:80421.








































































Fig. 6.3 Rates of mortality improvement for women in Austria, 1950–2013 (Data source: Human
Mortality Database)








































































Fig. 6.5 Rates of mortality improvement for women in Czech Republic, 1950–2013 (Data source:
Human Mortality Database)







































































England & Wales, Women
Fig. 6.7 Rates of mortality improvement for women in England & Wales, 1950–2012 (Data
source: Human Mortality Database)








































































Fig. 6.9 Rates of mortality improvement for women in France, 1950–2013 (Data source: Human
Mortality Database)



































Fig. 6.10 Rates of mortality improvement for women in western Germany, 1956–2012 (Data




































Fig. 6.11 Rates of mortality improvement for women in eastern Germany, 1956–2012 (Data
source: Human Mortality Database)








































































Fig. 6.13 Rates of mortality improvement for women in Italy, 1950–2011 (Data source: Human
Mortality Database)








































































Fig. 6.15 Rates of mortality improvement for women in Netherlands, 1950–2011 (Data source:
Human Mortality Database)








































































Fig. 6.17 Rates of mortality improvement for women in Russia, 1959–2013 (Data source: Human
Mortality Database)








































































Fig. 6.19 Rates of mortality improvement for women in Spain, 1950–2013 (Data source: Human
Mortality Database)








































































Fig. 6.21 Rates of mortality improvement for women in USA, 1950–2013 (Data source: Human
Mortality Database)
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Another vertical pattern, suggesting a period effect, can be observed in many
countries during the 1970s. Among the countries presented here, Australia (p. 46),
Finland (p. 52), western Germany (p. 54), Spain (p. 63) and the United States
(p. 65) belong to that group, for instance. We can only speculate that the so-called
“cardiovascular revolution” (Meslé and Vallin 2006b) played an important role. It
was during the 1970s that medical procedures such as bypass surgery, pace makers
to treat cardiovascular diseases were introduced to larger parts of the population.
But it was not only the treatment but also the prevention of cardiovascular diseases
by drugs such as beta blockers that received a major boost during that time frame.
Many countries that benefited from that period effect during the 1970s exhibit
a pattern that resembles a cohort effect in the years thereafter for persons aged
approximately 40–80 in the 1970s. It could be argued that those green and red colors
along the 45ı line that last into the 2000s could be interpreted as a protective effect
for those cohorts that benefited first from the new treatment and prevention methods
during the 1970s. Please note that this does not imply that subsequent cohorts did
not benefit from the advances of the 1970s. This would have resulted in gray cohorts
areas. Instead we typically encounter positive developments, just at a smaller scale
than the ones of the initial cohorts. This pattern is most visible for Japan (p. 58),
Spain (p. 63), Finland (p. 52) and Australia (p. 46), and—to a lesser degree—in
France (p. 53) and western Germany (p. 54).
This period effect followed by a cohort effect is not a universal finding, however.
Even among western European countries, we detect some outliers. The most
prominent example is probably the case of Danish women (p. 50). While the past
20 years or so have shown moderate to strong survival improvements across most
of the age range as indicated by the green and red colors, there is one issue that sets
Denmark apart from other countries: A cohort effect from the 1960s that lasted well
into the early 1990s with stagnating survival, shown in white, or even increasing
mortality as suggested by the gray shades. It has been now conclusively shown that
Danish women born between the two world wars and their relatively high smoking
prevalence are at the root of this cohort effect (e.g., Jacobsen et al. 2002, 2004, 2006;
Lindahl-Jacobsen et al. 2016). This cohort effect coincides with relatively minor life
expectancy gains among Danish women during that period. Also the United States
(p. 65) features a strange pattern. It will be investigated further when we analyze
rates of mortality improvement for selected causes of death in Chap. 7.
Similar to the Danish situation, modest life expectancy gains or even losses
during the 1970s and 1980s have also been observed in several eastern European
countries. But it has not been caused by a cohort effect as the vertical shapes for
Hungary (p. 56), the Czech Republic (p. 49), Poland (p. 60) or the former GDR
(p. 55) indicate a clear period effect. It can be rather expected that those countries
could not (yet) reap the benefits of the cardiovascular revolution that many western
countries experienced during that time period. This is supported by the subsequent
strong period effects in many of those countries. The most prominent example is
probably the former GDR/eastern Germany. When Germany re-unified, there was a
difference of almost 3 years among women for life expectancy at birth. Just 15 years
later, the difference virtually disappeared for females between the two parts of
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Germany. Germany’s Federal Health Reporting database (www.gbe-bund.de) can
be queried to show that mortality of the circulatory system declined by 47% in
eastern Germany between 1990 and 2005.
The most turbulent mortality history during the last 60 years has been probably
experienced by Russia and other former Soviet republics (see Figs. 6.4, 6.17,
and 6.20 on pages 48, 61, and 64). Since the 1960s, those countries (or then
parts of the USSR) have seen sudden changes in mortality spikes and subsequent
survival improvements. Those were typically period effects as the vertical patterns
in those figures indicate. While we have only focused on mortality of women, we
included the case of Russian men in Fig. 6.18 on page 62. There were a few years
featuring survival improvements for instance during the mid 1980s, coinciding with
Gorbachev’s anti-alcohol campaign (Leon et al. 1997), life expectancy of Russian
men declined by more than 5 years between 1965 and 2000. France Meslé (2004)
points out in her decomposition analysis, that the majority of life years lost was
due to increasing mortality from circulatory diseases and violent deaths. Those are
precisely the causes, which are mainly responsible for the increase in life expectancy
during the first decade of the 2000s: “Our analyses have shown that the recent
improvements in life expectancy have mainly been driven by reductions in mortality
from circulatory diseases and external causes” (Shkolnikov et al. 2013, p. 930).
The last few years of our observation period provide a mixed result. Life
expectancy continued to increase for Russian men, primarily caused by annual
survival improvements of more than 3% at ages 70 and above. Mortality declined
modestly between ages 40 and 70. And there are some ages between 35 and 40
where mortality increased slightly again. But it is too early to determine whether we
see another trend reversal.
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Chapter 7
Surface Plots of Rates of Mortality Improvement
for Selected Causes of Death in the United States
The current chapter shows how surface maps of rates of mortality improvement
can also be used to analyze causes of death. This might enable researchers to gain
better insights into the underlying mortality dynamics than merely looking at the
Lexis surface of rates of improvement for all-cause mortality. We selected the United
States for two reasons:
• Data on deaths are available as public use files since 1959 (National Center
for Health Statistics 1959–2015; National Bureau of Economic Research 1959–
2015). Information is included not only on age at death and sex of each deceased
individual but also on cause of death and many other variables. See Chap. 3,
starting on page 11, for further details about the more than 118 mio. deaths
contained in the data.
• The pattern of the rates of mortality improvement for women in the United
States looked different than in any of the other countries (see Fig. 6.21 on
page 65). Since the late 1970s/early 1980s, the US has not experienced any
prolonged period of survival improvements. Indeed, the United States gained
less years of life than most other western countries during the latter part of
the twentieth century. As a consequence the National Institute on Aging in the
United States “requested that the National Research Council (NRC) launch a
major investigation to clarify patterns in the levels and trends in international
differences in life expectancy above age 50” (Crimmins et al. 2011, p. 2).
We used again the same techniques and color schemes as in Chap. 6. To avoid any
spurious conclusions due to small numbers of deaths, we excluded deaths above age
95 and below age 20.
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Rates of Mortality Improvement,
Circulatory Diseases, Women
Fig. 7.1 Rates of mortality improvement for all circulatory diseases for women in the United
States aged 20–95 between 1959 and 2013 (Data source: Human Mortality Database, National
Center for Health Statistics, and National Bureau of Economic Research)
More than 50 mio. deaths—corresponding to almost 45% of all deaths—can be
attributed to diseases of the circulatory system. The ROMI plot for mortality due
to these causes is depicted in Fig. 7.1. Heart diseases (Fig. 7.2), e.g., myocardial
infarction, and cerebrovascular diseases (Fig. 7.3) such as stroke constitute about






























Rates of Mortality Improvement,
Heart Diseases, Women
Fig. 7.2 Rates of mortality improvement for heart diseases for women in the United States aged
20–95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for
Health Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
Cerebrovascular Diseases, Women
Fig. 7.3 Rates of mortality improvement for cerebrovascular diseases for women in the United
States aged 20–95 between 1959 and 2013 (Data source: Human Mortality Database, National
Center for Health Statistics, and National Bureau of Economic Research)
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95% of all deaths from circulatory diseases. We can draw at least two conclusions
from those figures:
• Circulatory diseases can not be the reason why (female) life expectancy in the
United States barely increased during the last two decades of the twentieth
century. We see major annual declines (three percent and more) in mortality due
to these causes.
• The pattern found for mortality from heart diseases and cerebrovascular diseases
as well as from the composite picture of all circulatory diseases resembles the
pattern we found in Chap. 6 for rates of mortality improvement from all causes
in many countries such as Spain, Japan, or Italy. At that time we were only able
to speculate that the “cardiovascular revolution” was the primary reason for the
observed pattern. While Figs. 7.1, 7.2, and 7.3 are no definite proof, we can feel
more certain about our suggestions.
So if circulatory diseases were the main reason for life expectancy gains in many
European countries during the 1980s and 1990s, why did life expectancy in the
United States not increase in a similar manner since mortality from heart diseases,
stroke and similar causes also declined remarkably in the US?
If circulatory diseases can be excluded, we turned our attention to malignant
neoplasms (“cancers”). They are responsible for more than one in five deaths.
Among the various cancer sites, we decided to look at three major sub-categories:
colorectal, breast and lung cancer (Figs. 7.5, 7.6, 7.7, and 7.8) in addition to
mortality from all cancers (Fig. 7.4).
Deaths from any kind of cancer for women (Fig. 7.4) show a mixed pattern:
Below age 50 we can detect a continuous trend of improving survival conditions
throughout most of our observation period. Lower mortality from cancer extends
also to higher and higher ages after the mid-1980s (Fig. 7.4). Those survival
improvements that show some characteristics of a cohort effect could be influenced
by declining mortality from colorectal cancers as suggested by Fig. 7.5. Also breast
cancer (Fig. 7.6) displays steady improvements albeit starting only in the 1990s.
The main cause for the poor development of female life expectancy during the late
twentieth century is probably lung cancer. Among the authors of this book, Fig. 7.7
on page 77 is the strongest cohort effect they have encountered when analyzing
rates of mortality improvement by cause of death. Also men (Fig. 7.8, p. 78) feature
such a strong cohort effect. The pattern for males is located further left on the Lexis
map, i.e., earlier in calendar time, supporting the idea of the “’cigarette diffusion’
explanation [. . . ] that convergence in male and female smoking is the byproduct of
a female lag in the process of cigarette adoption, diffusion, and abatement” (e.g.,
Pampel 2001, p. 388). Furthermore, our figures on lung cancer, in conjunction with
the detrimental effects shown in Fig. 7.9 for respiratory diseases, are in line with






























Rates of Mortality Improvement,
 All Cancers, Women
Fig. 7.4 Rates of mortality improvement for malignant neoplasms for women in the United States
aged 20–95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for
Health Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
 Colorectal Cancer, Women
Fig. 7.5 Rates of mortality improvement for colorectal cancer for women in the United States
aged 20–95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for
Health Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
 Breast Cancer, Women
Fig. 7.6 Rates of mortality improvement for breast cancer for women in the United States aged
20–95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for
Health Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
 Lung Cancer, Women
Fig. 7.7 Rates of mortality improvement for lung cancer for women in the United States aged 20–
95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for Health
Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
 Lung Cancer, Men
Fig. 7.8 Rates of mortality improvement for lung cancer for men in the United States aged 20–
95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for Health
Statistics, and National Bureau of Economic Research)






























Rates of Mortality Improvement,
Respiratory Diseases, Women
Fig. 7.9 Rates of mortality improvement for respiratory diseases for women in the United States
aged 20–95 between 1959 and 2013 (Data source: Human Mortality Database, National Center for
Health Statistics, and National Bureau of Economic Research)
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Wang and Preston (2009, p. 398) who argue that “[b]ecause of changes in smoking
behavior that have already occurred or that can be reliably projected, American
mortality is likely to fall more rapidly than is commonly anticipated.”
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Chapter 8
Surface Plots of Age-Specific Contributions to
the Increase in Life Expectancy
8.1 How to Estimate Age-Specific Contributions to the
Change in Life Expectancy
Different perspectives can provide different insights into mortality dynamics.
Chapters 6 and 7 investigated the relative change of death rates over time. The
same “ROMI” does not necessarily translate to the same change of life expectancy,
though, neither over time nor at different ages: A large reduction of infant mortality
in the past had a major impact on life expectancy whereas the same proportional
reduction would affect life expectancy only slightly since infant mortality is already
(and thankfully) at a very low level. Analogously, the same rate of mortality
improvement at the same time may have considerably different effects on life
expectancy. For instance, an annual mortality decline by x per cent at age 80 has
a much larger impact on life expectancy than a decline by x per cent at age 100.
We decided therefore to estimate the age-specific contributions to the change in
life expectancy. Among the various methods available—see Canudas-Romo (2003)
for an overview—we applied the approach of Arriaga (1984) using the exposition
of Preston et al. (2001, pp. 64–65). Having data for single ages available, allowed
us to further simplify the notation. With the conventional life table lx for the life
table survivors at age x, Lx for the number of life years lived at age x, and Tx for the
number of life years lived at age x and above, we can estimate x, the contribution of
mortality at age x to differences in life expectancy between two points (or between






















The age-specific contribution to the difference in life expectancy, x, consists
of two parts. The first part (until the C sign) estimates the direct effect, i.e., the
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change in life expectancy only due to the change in mortality at this given age x.
The second part is the sum of an indirect effect and an interaction effect (Preston
et al. 2001, p. 64). A geometric explanation might help to understand what is meant
by this second component as it often appears to be confusing: Life expectancy can
be interpreted as the area under the survival curve. In case of a decline in mortality
at age x at time point t the survival curve at this age is higher than at time point
t  1. This is meant by the direct effect. For the sake of simplicity, let’s assume
that mortality only changed at age x. Nevertheless, the survival curve will be also
higher at age x C1: A survival curve where the survival at age x C1 was at the same
level as at t  1 would require an increase in mortality. This “wake” of a change in
mortality at one age affecting the survival function at subsequent ages is estimated
by the second component.
We followed exactly the same procedure as in Chap. 5 to obtain the required
death rates: Raw death rates, based on death counts and corresponding exposure
times from the Human Mortality Database (HMD, 2017), were smoothed assuming
Poisson distributed death counts using Camarda’s MortalitySmooth package
(Camarda 2012, 2015). The life table functions lx, Lx, and Tx were estimated using
the approach outlined in Chapter 3 of Preston et al. (2001). The values for ax, the
mean duration lived at age x by those who died at age x, were taken from the HMD.
While any kind of difference in calendar time could be used, we decided to
estimate the age-specific contributions within an interval of ten years. I.e., we
compared 1960 to 1950, 1961 to 1951, . . . . The years on the x-axis in Figs. 8.1,
8.2, 8.3, 8.4, 8.5, 8.6, 8.7, 8.8, 8.9, 8.10, 8.11, 8.12, and 8.13 refer to the latter
time point. Thus, the values at any age x in year 1980 denote the contribution
of changing mortality at age x between 1970 and 1980. The choice of a ten year
difference is, of course, arbitrary but it allowed us also to express the contribution
in “meaningful” units: We used days and weeks and—in exceptional cases of
substantial improvements or deterioriation in survival—months. The surface maps
were plotted using a terrain color scheme: Green indicates moderate contributions
to life expectancy. When the color turns to brown, that age alone contributed at least
one week to the increase in life expectancy during the decade of observation. Very
bright brown areas depict contributions of one month or more. Blue colors denote
negative contributions. Just like deeper shades of blue suggests lower depths below
sea level on geographic maps, they indicate here changes in age-specific mortality
that bring life expectancy down.
Again, we have not included the whole set of countries from the HMD but rather
a subset of countries with rather peculiar features, which we already pointed at in
previous chapters.
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Belarus, Men: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.1 Age-specific contributions to the increase in life expectancy among men during the past
10 years in Belarus, 1969–2014 (Data source: Human Mortality Database)
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Denmark, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.2 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Denmark, 1960–2014 (Data source: Human Mortality Database)
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France, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.3 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in France, 1960–2014 (Data source: Human Mortality Database)
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Germany (East), Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.4 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Germany (East), 1966–2013 (Data source: Human Mortality Database)
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Germany (East), Men: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.5 Age-specific contributions to the increase in life expectancy among men during the past
10 years in Germany (East), 1966–2013 (Data source: Human Mortality Database)
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Germany (West), Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.6 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Germany (West), 1966–2013 (Data source: Human Mortality Database)
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Japan, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.7 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Japan, 1960–2014 (Data source: Human Mortality Database)
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Netherlands, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.8 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Netherlands, 1960–2012 (Data source: Human Mortality Database)
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Poland, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.9 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Poland, 1968–2014 (Data source: Human Mortality Database)
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Poland, Men: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.10 Age-specific contributions to the increase in life expectancy among men during the past
10 years in Poland, 1968–2014 (Data source: Human Mortality Database)
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Russia, Men: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.11 Age-specific contributions to the increase in life expectancy among men during the past
10 years in Russia, 1969–2014 (Data source: Human Mortality Database)
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Sweden, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.12 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in Sweden, 1960–2014 (Data source: Human Mortality Database)
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USA, Women: Contribution of Single Ages 
 to the Increase in Life Expectancy Over a Period of 10 Years
Fig. 8.13 Age-specific contributions to the increase in life expectancy among women during the
past 10 years in USA, 1960–2014 (Data source: Human Mortality Database)
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8.2 Results
Figures 8.1 and 8.11 for Belarus and Russia, respectively, reiterate our findings
of strong period effects from Chap. 6. Although our focus is mainly on mortality
dynamics of women, we selected data for men here on purpose since the decline in
life expectancy and fluctuations over time were more pronounced for males than for
females (e.g., Meslé 2004).
The vertical ROMI patterns in Fig. 6.18 (Chap. 6, p. 62) suggested that all ages
between 15 and 75 were affected by the strong positive and negative period effects
in Russia. Figure 8.11 in the present chapter, though, allows us to narrow down
the age-range if we are interested in the contribution to changes in life expectancy.
Compared to ten years earlier, changing mortality of men aged between 20 and 50
years appears to be the main contributor to the increase in life expectancy during
the 1980s, fueled at least partly by Gorbachev’s anti-alcohol campaign (Leon et al.
1997). As we have already seen in Chap. 6, the end of the Soviet Union in the
early 1990s induced a major rise in mortality in Russia and other successor states.
It seems almost impossible that mortality increased as much at ages 50 to 65 in
Belarus (Fig. 8.1) that some single ages depressed life expectancy by one month or
more within a ten-year interval. Even more astonishing are the results for Russia
(Fig. 8.11) where the change in mortality at single ages between 40 and 55 caused a
decline of life expectancy of six weeks and more.
The end of socialism/communism in eastern Europe in the early 1990s was less
of a problem for Poland, though, serving as an example of a country from the former
Warsaw Pact (see Fig. 8.9 for women and Fig. 8.10 for men). Whereas mortality also
increased for men at working ages throughout the 1970s and 1980s, it took only a
few years after the fall of the iron curtain, to see exactly the same kind of ages
contributing two weeks or more to gains in life expectancy throughout a decade—a
development, which appears to be still ongoing. It took even less time for Polish
women to benefit from the regime change than for their male peers. The increase
in life expectancy almost immediately after 1989/1990 was primarily triggered by
survival improvements among women aged 60–85 years.
A similar picture as for Poland emerges for females and males from the former
“GDR” (Figs. 8.4 and 8.5): Stagnating or even increasing mortality throughout the
1970s and 1980s among men at working ages does not immediately disappear
with the end of the political regime. Indeed, mortality even increased slightly for
males aged about 30–50 years. Marc Luy (2004, p. 133) showed that “[t]his effect
can be attributed almost exclusively to diseases of the digestive system (mainly
due to diseases of the liver) and the cause of death chapter ’injury, poisoning
and certain other consequences of external causes’ (mainly resulting from traffic
accidents).” The group that was the fastest to adapt to the new situation were
German women from the former eastern part. Faster than Polish women or men
from eastern Germany, improvements in survival started immediately in 1990.
Declining mortality where single ages contributed at least two weeks to the increase
in life expectancy within ten years were representative of the first two decades after
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Germany’s reunification. Women aged 65 to 80 contributed even one month or more
from the mid-1990s to the mid-2000s.
A contribution of two weeks or more of single ages to the increase in life
expectancy was already common among women in the former western part of
Germany since the 1970s (Fig. 8.6). In fact, the peak of one month and more for
women aged 65 to 80 could be interpreted as an indicator for the catching-up period
of the “cardiovascular revolution” that already started in the 1970s in the former
FRG and many other western countries—see, for instance, the figures for French
and Swedish women in Figs. 8.3 and 8.12.
Sweden was actually one of the first countries with a sustained decline in old-age
mortality as pointed out by Kannisto (1994). As reflected by the narrowing bands
of two weeks and more in Fig. 8.12, contributions of older ages to the increase in
life expectancy have been smaller than in some other “vanguard” countries such as
France or Japan. Drefahl et al. (2014) demonstrate that different trends for mortality
from circulatory diseases were the main reason that Sweden is “losing ground”.
Once again we can detect a clear cohort effect in Denmark (Fig. 8.2) for the
women born between the two world wars. While the blue colors indicate worsening
survival, the detrimental effects were just a few days at most for single ages, much
less than what we observed for Belarus or Russia (Figs. 8.1 and 8.11). As we have
shown in previous chapters, the United States (Fig. 8.13) also deviated negatively
from the international trend observed in many western countries. We can expect
that the seemingly interrupted pattern between 1980 and 2000 can be attributed to
the severe effects of lung cancer, which we demonstrated in Chap. 7.
Another country where life expectancy improvements were not as high as
anticipated during the 1980s and 1990s were the Netherlands (Fig. 8.8). The typical
explanation of the smoking epidemic and lung cancer does not hold here, though.
Peters (2015, p. 185), for example, argues that “[t]he internationally deviating Dutch
trends over the past three decades are not explained by changes in the impact of
smoking. Accounting for the impact of smoking revealed simultaneous trend breaks
in mortality decline of Dutch men and women around 2002. These breaks occurred
most likely due to sudden changes in healthcare expenditures that explained about
half of the acceleration in life expectancy during 2000–2009.”
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Chapter 9
Seasonality of Causes of Death
9.1 Decomposing Seasonal Data
The majority of deaths in most countries can be attributed to causes that feature
a distinct seasonal pattern. Figure 9.1 depicts the relative monthly frequencies of
nine selected causes of death in the United States for women and men combined for
the years 1959–2014. The reported number of counts in parentheses in the title of
each panel is the actual number of deaths. To control for varying lengths of months,
the monthly columns in each histogram have been adjusted for a uniform length
(30 days). The horizontal reference lines denote the expected value of a uniform
distribution (=1/12).
The typical distribution follows a sinusoidal pattern with highest mortality in
winter and relatively few cases in the summer. Primarily, those are circulatory
diseases (e.g., heart diseases, cerebrovascular diseases)—as shown in the first row
of Fig. 9.1—and respiratory diseases such as chronic obstructive pulmonary disease
(“COPD”), pneumonia or influenza (Eurowinter Group 1997, 2000; Mackenbach
et al. 1992; Kunst et al. 1990; Rau 2007; Yen et al. 2000; Seretakis et al. 1997),
which are displayed in three horizontal panels in the middle of Fig. 9.1.
If diseases, and ultimately, mortality occur seasonally, it has been argued that
“an environmental factor has to be considered in the etiology of that disease”
(Marrero 1983, p. 275).1 The main environmental factor to trigger higher mortality
during winter for circulatory diseases and respiratory diseases—the rows on top of
1It should be noted that the impact of environmental factors on diseases and deaths is as not a
finding of the latter part of the twentieth century but is well known for more than 2000 years. In
about 400BC Hippocrates started his treatise “On Airs, Waters, and Places” with the following
words: “Whoever wishes to investigate medicine properly, should proceed thus: in the first place
to consider the seasons of the year, and what effects each of them produces for they are not at all
alike, but differ much from themselves in regard to their changes.”
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Fig. 9.1 Seasonality of selected causes of death in the United States for both sexes combined for
the years 1959–2014. The counts reported in each panel denote the actual numbers of death. The
relative frequencies in each histogram are adjusted for a uniform length of 30 days per month (Data
source: National Center for Health Statistics and National Bureau of Economic Research)
Fig. 9.1—is well understood: temperature. Cold temperatures constrict the blood
vessels and change the composition of the blood; furthermore, low temperatures
facilitate the survival of bacteria in droplets and increase the risk for pulmonary
infections (Eurowinter Group 1997, 2000; Huynen et al. 2001; Rau 2007).
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The patterns observed in the three panels at the bottom of Fig. 9.1 deviate from
the ones for circulatory and respiratory diseases above. Motor vehicle accidents do
not peak in winter but around July and August. Many people assume that the reason
for the peak in all-cause mortality is due to suicides in winter. The middle panel at
the bottom of Fig. 9.1 illustrates why this assumption is wrong for three reasons: (1)
The seasonal pattern is less pronounced for suicide than for other causes. (2) If one
can speak of a seasonal pattern at all, the peak occurs definitely not during winter. (3)
The 30,000 observed deaths are less than 1.5% of all deaths; not enough to shape
the pattern for all causes. Lung cancer, whose impact on mortality in the United
States was discussed in previous chapters, is—like many malignant neoplasms—an
example of no or only negligible seasonality.
Figure 9.1 displays an aggregated picture of monthly deaths. In our analysis we
want to investigate, however, whether the seasonal pattern for selected causes of
death differs by age as well as whether the seasonal pattern changed over calendar
time. The multiplicative model2 suggested by Eilers et al. (2008) to decompose
seasonal data allows such an analysis. The model is, at its core, another application
of smoothing data via P-splines (Eilers and Marx 1996) as in Chap. 5. It is rather
flexible since it allows the estimation not only of counts but also of rates. Exposures
are then included as log offsets if the latter is desired, similar to Camarda’s approach
(2012, 2015) employed in Chaps. 5, 6, and 7. We use the model in its most simple
form: The model is estimating counts assuming an annual unimodal pattern in the
data. Not allowing for bimodal patterns or even higher frequencies should not induce
any problems in our analysis since the causes in which we are interested in feature
clear patterns with one peak and one trough (see Fig. 9.1).
We model the expected value of death counts y over age a and time t, ta D
E.yta/, to be Poisson distributed using a log-link function
log .ta/ D vta C fta cos .!t/ C gta sin .!t/
with ! D 2=p, where p is the period. In our case of monthly values p D 12.
Further technical details are given in Eilers et al. (2008).
The estimation yields three smooth matrices/surfaces, vta for the trend as well as
the smooth cosine and sine surfaces fta and gta. The trend surface captures any major
changes in the overall pattern that could be caused by varying population sizes,
survival improvements, competing risks . . . . We are mainly not interested in this
trend surface nor in the the actual sine and cosine surfaces. The two latter surfaces
allow us, however, to obtain an estimate for the amplitude and the phase over age
and time via simple trigonometric functions. The latter denotes the location of the
annual peak of the death counts and is expressed in the difference in days from the
1st of January; i.e., a value of 30 corresponds to late January whereas -30 indicates
that mortality is highest in the beginning of December.
2Since the logarithm of death counts is modeled, it actually becomes an additive model.
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9.2 Results
Our data and results are displayed in five panels for each selected cause. On the
first page for each cause, we show the observed (“raw”) monthly numbers of death
by calendar time and single age (adjusted for a duration of 30 days) in the upper
panel. The panel below plots the fit of the model, i.e., the combined pattern of
the trend and the sine and the cosine surfaces, which is equivalent to the observed
counts minus the (raw) residuals; see, for example, Fig. 9.2 on page 103 for mortality
from all causes combined for women. Our main interest is displayed on the second
page for each cause. The top panel shows the estimated trend surface vat. In the
case of seasonality of all-cause mortality among US women (Fig. 9.3), we can
see that the number of deaths from that category increases with age and reaches
its “hotspot” for octogenarians before the numbers of death decline again. As the
trend surface plots the seasonally-adjusted density of deaths, the lower number of
deaths for nonagenarians are the consequence of less people being alive rather than
a decline in the risk of dying. Even without the additional seasonal component,
up to 3,500 women died at a single age during a single month. The height of
“excess mortality” is depicted by the amplitude in the middle panel. Higher ages
correspond not only to higher mortality; the colors and the contour lines suggest that
mortality differences between winter and summer also become larger at higher ages.
Increasing seasonality with age has already been described by Adolphe Quetelet in
1838 and is typically also found in more contemporary populations (Feinstein 2002;
McDowall 1981; Rau and Doblhammer 2003; Rau 2007). Over time we can not
really discern a clear trend. It seems rather that deaths for 70-year-old women in the
US are about 10% higher during the peak season and about 15% higher for 90-year-
old women than on average during a year. If we multiply the seasonal estimate of
a given age and calendar time (e.g., 1.1) with the corresponding square of the trend
surface (e.g., 1,500 deaths), we obtain the fitted value (e.g., 1,650 deaths) shown
in the lower panel on the previous page. When the peak season occurs in a year is
illustrated in the lower panel. The colors indicate a value slightly below 30. Hence,
deaths occur most often in the end of January, regardless of age or calendar year.
The corresponding plots for men are depicted in Figs. 9.4 and 9.5. While male
mortality is higher than female mortality at any age—at least in highly developed
countries, the seasonal characteristics are rather similar between the two sexes: The
proportion of excess deaths during winter varies between 5% at age 50 and 15%
at age 90 with no apparent period effect. Also the part of the year when deaths
peak among men occurs at the end of January. Those seasonal mortality similarities
between women and men are not only present for all-cause mortality but also for
most causes of death. That is why we restricted ourselves to show only the results
for women but they apply equally to men. We show the results for men only in the
case of motor vehicle accident because much less women die of that cause.
The largest subcategory analyzed by us in this chapter is death from heart
diseases (see Figs. 9.6 and 9.7, pp. 107–108). Up to 1,300 deaths were recorded


































Fig. 9.2 Seasonality of mortality from all causes in the United States, 1959–2014, women, raw
counts (adjusted for length of month) and fitted model (Data source: Human Mortality Database)
104 9 Seasonality of Causes of Death
Fig. 9.3 Seasonality of
mortality from all causes in
the United States, 1959–2014,
women, estimated trend
surface (top panel), amplitude
(middle panel), and phase
















































































































Fig. 9.4 Seasonality of mortality from all causes in the United States, 1959–2014, men, raw counts
(adjusted for length of month) and fitted model (Data source: Human Mortality Database)
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Fig. 9.5 Seasonality of
mortality from all causes in
the United States, 1959–2014,
men, estimated trend surface
(top panel), amplitude
(middle panel), and phase
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Fig. 9.6 Seasonality of mortality from heart diseases in the United States, 1959–2014, women,
raw counts (adjusted for length of month) and fitted model (Data source: Human Mortality
Database)
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Fig. 9.7 Seasonality of
mortality from heart diseases
in the united states,
1959–2014, women,
estimated trend surface (top
panel), amplitude (middle
panel), and phase (bottom













































































seasonal decomposition, this is the outcome of about 10 to 15% of excess deaths
during the peak season. Also here we can not detect any period effects. In contrast
to all-cause mortality with its peak at the end of January, deaths from heart diseases
are highest at the end of February since the colors indicate a value of slightly below
60.
Most deaths from circulatory diseases can be attributed either to heart diseases or
to cerebrovascular diseases. We analyzed the seasonal pattern of the latter category
for women in Figs. 9.8 and 9.9 for men on pages 112–113. Comparable to heart
diseases, the corridor with the largest number of deaths is moving to higher ages;
the actual numbers are much smaller than for the other category, though. The extent
of the seasonal pattern is remarkably similar to heart diseases. The amplitude is
elevated again by about 10% around age 70 with larger fluctuations at higher ages
and smaller fluctuations at younger ages. A clear trend over time is again not visible.
Cerebrovascular diseases peak a bit earlier than heart diseases as suggested by the
lower panels of Figs. 9.9 and 9.11. The highest number of deaths can be typically
observed before the 30th day of the year, i.e., sometime between the middle and the
end of January.
The Eurowinter group investigated the impact of cold temperatures on mortality
about 20 years ago (e.g., Eurowinter Group 1997). They looked at ischaemic heart
disease, cerebrovascular diseases, and respiratory diseases. As those three categories
are mainly responsible for the seasonal pattern, we also analyzed the pattern for
respiratory diseases, please see Figs. 9.12 and 9.13 on pages 114 & 115. The
observed number of deaths is a bit higher than for cerebrovascular diseases. The
seasonal decomposition on the second page shows that this is primarily the outcome
of large seasonal fluctuations. Even the highest values in the trend surface on top
are smaller than the corresponding values for cerebrovascular diseases. Excess
deaths are, however, not only 10 to 15% higher in winter than throughout the year
in general. The middle panel clearly illustrates that deaths from diseases such as
pneumonia, influenza, COPD, etc. are at least 30% higher during peak season, which
occurs at the end of February as the plot for the phase at the bottom illustrates. In
contrast to the previously discussed two groups of circulatory diseases, the darker
shades of blue during more recent years in the plot of the amplitude for respiratory
diseases suggest that seasonal fluctuations became smaller over time.
Although motor vehicle accidents are by no means a major cause of death
category, we decided nevertheless to include it. In the worst case 200 people of
a given age died during a single month. The raw counts and fitted counts in
Fig. 9.14 and the trend surface in Fig. 9.15 demonstrate that the period with the
highest numbers of deaths is (thankfully) over. It occurred during the 1970s and
1980s to men aged around 20 years. The same plots show also that those men,
born between 1950 and about 1965 suffer from a higher number of deaths also
at higher ages. Since we are not looking at mortality per se but at death counts,
this cohort effect is not necessarily the outcome of higher mortality; it could also
be caused by the high number of births during those years (“baby boomers”). It
is interesting to note, however, that we can also here detect a pattern on the 45ı
line for the seasonal amplitude and for the phase, which should be unaffected by



































Fig. 9.8 Seasonality of mortality from cerebrovascular diseases in the United States, 1959–2014,
women, raw counts (adjusted for length of month) and fitted model (Data source: Human Mortality
Database)
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Fig. 9.9 Seasonality of
mortality from
cerebrovascular diseases in
the United States, 1959–2014,
women, estimated trend
surface (top panel), amplitude
(middle panel), and phase







































































































Fig. 9.10 Seasonality of mortality from cerebrovascular diseases in the United States, 1959–2014,
men, raw counts (adjusted for length of month) and fitted model (Data source: Human Mortality
Database)
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Fig. 9.11 Seasonality of
mortality from
cerebrovascular diseases in
the United States, 1959–2014,
men, estimated trend surface
(top panel), amplitude
(middle panel), and phase
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Fig. 9.12 Seasonality of mortality from respiratory diseases in the United States, 1959–2014,
women, raw counts (adjusted for length of month) and fitted model (Data source: Human Mortality
Database)
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Fig. 9.13 Seasonality of
mortality from respiratory
diseases in the United States,
1959–2014, women,
estimated trend surface (top
panel), amplitude (middle
panel), and phase (bottom
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Fig. 9.14 Seasonality of motor vehicle accidents in the United States, 1959–2014, men, raw
counts (adjusted for length of month) and fitted model (Data source: Human Mortality Database)
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Fig. 9.15 Seasonality of
motor vehicle accidents in the
United States, 1959–2014,
men, estimated trend surface
(top panel), amplitude
(middle panel), and phase
















































































































Fig. 9.16 Seasonality of mortality from all cancers in the United States, 1959–2014, women, raw
counts (adjusted for length of month) and fitted model (Data source: Human Mortality Database)
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Fig. 9.17 Seasonality of
mortality from all cancers in
the United States, 1959–2014,
women, estimated trend
surface (top panel), amplitude
(middle panel), and phase
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Fig. 9.18 Seasonality of mortality from lung cancer in the United States, 1959–2014, women, raw
counts (adjusted for length of month) and fitted model (Data source: Human Mortality Database)
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Fig. 9.19 Seasonality of
mortality from lung cancer in
the United States, 1959–2014,
women, estimated trend
surface (top panel), amplitude
(middle panel), and phase








































































122 9 Seasonality of Causes of Death
a larger population at risk since the trend surface accounts for it. The panel in the
middle of Fig. 9.15 shows lowest seasonality for the birth cohort born before the
baby boomers mentioned above. Also the change of the period when most deaths
from motor vehicle accidents occur throughout a year features a cohort pattern.
Whereas deaths from car accidents and similar causes peaked late in fall for older
cohorts, the highest number of deaths for baby boomers and later generations are
recorded at least 120 days before the 1st of January, which corresponds to August
of a year.
We want to conclude this chapter by showing that cancers in general (see
Figs. 9.16 and 9.17 on pages 118–119) and lung cancer (see Figs. 9.18 and 9.19
on pages 120–121) are examples of non-seasonal diseases. Clearly the fluctuations
throughout a year are barely noticable as the middle panels of Figs. 9.17 and 9.19
illustrate.
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International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing,
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Chapter 10
Surface Plots for Cancer Survival
10.1 Introduction and Overview: The Impact of Cancer on
Mortality in the United States
With 23.4% or 614,348 out of 2,626,418 deaths in the United States, heart diseases
remained the leading cause of the death in the United States in 2014 (CDC/NCHS
2015). Hence, heart diseases contributed most to the age-standardized crude death
rate in that year. The absolute level of mortality from heart diseases and other
circulatory diseases diminished remarkably during recent decades as we show in
Fig. 10.1. To avoid spurious results from the changing age composition of the
population, we used the population of the year 2000 to age-standardize the rates.
During the observed 60 years, mortality—as measured by the age-standardized
crude death rate—dropped steadily for women as well as for men. This trend of
declining mortality from circulatory diseases and rather stagnant cancer mortality
may result in a reversal of the leading group of causes of death in the near future
when more people might die of malignant neoplasms than of heart diseases or
stroke.
The converging trajectories of these two major causes of death can be also
presented from the perspective of cause-elimination life tables (results not shown
here; see, for instance Preston et al. (2001) or Kintner (2004) for the methodology):
If circulatory diseases had been non-existent, life expectancy at birth would have
been 11 years higher in the 1960s. This gap decreased to about 4 years during the
most recent years (3.62 for women, 4.16 for men), whereas the impact of eradicating
cancer remained relatively stationary over time for malignant neoplasms.
The proportion of deaths from cancer in relation to all causes varies considerably
by age as well as over time as we show in Fig. 10.2. The marginal distribution over
age is bimodal. A local peak is reached at childhood ages with the main contributing
cancers being leukemia and lymphoma as pointed out in Moore and Hurvitz (2009).
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Fig. 10.1 Age-standardized crude death rates by cause and sex (left panel: women; right panel:
men) in the United States from 1959–2014 (Data source: Own estimation based on data from the
Human Mortality Database and the National Center for Health Statistics. The population of the
year 2000 was used as the standardization population)
The age when the global peak is reached depends on the sex. 40% or more of all
deaths of women around age 50 can be attributed to cancers whereas the largest
proportion among men is reached between ages 60 and 70.
10.2 Dynamics of Cancer Survival by Cancer Site
People are usually not healthy and then die suddenly of a chronic, non-
communicable disease such as cancer. In a very simplified manner, we can regard
this as a two-step process: (1) People are healthy and then are diagnosed with a
certain chronic disease x. (2) People who are diagnosed with disease x die of x or of
another disease. The SEER data allow us to investigate developments for both steps.
We can look at incidence data for the first step and see how incidence has changed
over time by age. This might allow us to make inferences about the successes and
failures of cancer prevention. We focus, however, on the second step: Analyzing
survival from the moment of diagnosis to death. Thus, our focus is rather on the
successes and failures of cancer treatment.
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Fig. 10.2 Proportion of deaths from cancer in relation to all causes (left panel: women; right
panel: men) in the United States at ages 0–100 from 1959–2010 (Data source: National Center for
Health Statistics)
We decided to base our analysis on the five year survival rate. According to
the National Cancer Institute (2017) it is the “percentage of people in a study or
treatment group who are alive 5 years after they were diagnosed with or started
treatment for a disease, such as cancer.”1 We use three different operationalizations
of five-year survival:
1. For each cancer site and sex we estimate by single calendar year and single
age how many persons are still alive 60 months after diagnosis. Thus, the
first approach measures the survival chances in general of someone who was
diagnosed with a specific cancer.
2. Obviously, the first operationalization is highly dependent on age: someone aged
95 years has much lower survival chances in general than someone aged 45 years
with the same diagnosis. The interest is often not on survival/mortality in general
but on mortality due to the diagnosed disease. We therefore estimated also the
1Since it is a percentage/proportion, we wonder why the term “rate” has become so commonly
used.
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probability that someone will not die of the diagnosed cancer within 5 years.
This second operationalization is sometimes called “corrected survival rate”, “net
survival” or “disease-specific survival” (Parkin and Hakulinen 1991, p. 167). We
use the last term.
3. While the first two approaches describe the risk of dying of any cause (1) or
of the diagnosed cancer (2), the third approach compares the survival chances
of the diagnosed individuals with the general population. The ratio of observed
survival to expected survival is called “relative survival” and can be traced
back to Berkson and Gage (1952). Relative survival is “defined as the observed
survival of the cancer patients divided by the expected survival of a comparable
group from the general population, free from the cancer under study” (Talbäck
and Dickman 2011, p. 2626). The observed survival rate for relative survival
corresponds to our first approach, i.e., the probability of surviving from all causes
of death. The most common methods to estimate relative survival (e.g., Ederer
I, Ederer II, Hakulinen) differ with regard to the estimation of expected survival,
though (Cho et al. 2011). As shown by Rutherford et al. (2012, p. 20), “[t]aking
age into account [. . . ] removes most of the differences between the methods.”
Since we analyze by single ages and single calendar years, the choice of method
to estimate expected survival is less of a problem. We estimated expected survival
with life table data from the Human Mortality Database (2017): Expected five
year survival for 55 year old women in the year 2000 was the probability to
survive age 55 in the year 2000 multiplied by the probability to survive age 56 in
the year 2001, . . . multiplied by the probability to survive age 59 in the year 2004.
Using the general population instead of the general population free from cancer
violates the definition of relative survival. It has been done and justified, however,
since the inception of the method (please see Appendix Note 2 of Berkson
and Gage (1952) or Ederer et al. (1961)). Also recent papers such as Talbäck
and Dickman (2011, p. 2626 and Table 2) argue “that the bias is sufficiently
small to be ignorable for most applications.” Not accounting for the inclusion
of cancer patient mortality becomes a problem only for the oldest subjects and
follow-up times of 10 years or more. We would also argue that our estimates
for five-year survival are sufficiently close to the official estimates. For example,
SEER estimates relative survival of women diagnosed with breast cancer aged
50–64 years to be 90.1% during the period 2007–2013.2 Our results for the most
recent 3 years of our analysis varied between 90.05% and 91.08%.
The three approaches are featured in a panel each of Fig. 10.3 for breast cancer.
We restricted our analysis of breast cancer to women although men can die from it
as well. Our estimates for single year and age for breast cancer as well as for all
other cancer sites have been smoothed, again using P-Splines as outlined in Chap. 5

































































































































    































Fig. 10.3 Five year survival for breast cancer at ages 30–95 from 1973–2005. Left panel:
Probability to survive for 5 years after diagnosed with breast cancer (any cause). Middle panel:
Probability of not dying from breast cancer within 5 years after diagnosis. Right panel: Five year
survival of women diagnosed with breast cancer in relation to five year survival of women in the
general population (Data Source: SEER and Human Mortality Database)
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The panel on the left denotes the probability to survive for another 5 years after
being diagnosed with breast cancer, regardless of the actual cause of death. The
figure exhibits an obvious age gradient: Values of 30% or less at ages above 90 are
the consequence that the women are not only at an elevated risk of dying from breast
cancer. Other causes, most notably circulatory diseases, further reduce the chances
to survive for five more years. Consequently, the upward trend of the contour lines
can not be interpreted as progress made against the lethality of breast cancer. Still it
provides the answer to the question “How likely is it that I survive for another five
years?” for someone who got diagnosed with breast cancer.
While the left panel takes all “exit” possibilities into account, the panel in the
middle looks only at death from breast cancer. As a consequence, one minus the
depicted value equals the probability to die from breast cancer within 5 years after
diagnosis. The rather vertical lines from about age 40 to about age 80 indicate that
the chance of surviving breast cancer for at least 5 years has increased over time.
For instance, the probability for 60-year-old women who got diagnosed with breast
cancer in 1980 to survive 5 years was 80%; the equivalent value in 2000 was higher
than 90%. To express it even more positively: The risk of dying was cut in half
within less than 20 years (1980: 1  0:8 D 20%; 1995 W 1  0:9 D 10%)!
The panel on the right of Fig. 10.3 shows “relative survival”, i.e., it illustrates the
relative survival disadvantage of those diagnosed with breast cancer in relation to
the general population. A level of one would indicate that there was no difference in
the chance to survive for five more years between someone with a cancer diagnosis
and the general population. Unfortunately—but also not surprisingly—women with
breast cancer have lower survival chances than the general population. We can
detect, however, progress over time. The excess risk is less than 10% in recent years
for women with breast cancer in comparison to the general population (contour line
of 0.9) whereas it was about 30% just 25 years earlier. It is important to point out
that the increasing values of the vertical lines suggest a clear period effect: Progress
against breast cancer was faster than progress in survival in general, regardless of
the age when the woman was diagnosed.
It is theoretically possible to observe relative survival estimates that are higher
than one. For instance, it could be the outcome of a selection effect: Persons that take
advantage of screening programs and other early preventive measures are possibly
leading rather healthy lifestyles. If those persons are diagnosed with a cancer that
is virtually non-lethal, their survival advantage of their health behavior might be
stronger than the additional mortality risk of the malignant neoplasm. Hence, it
can not be concluded that getting diagnosed with a certain cancer could actually
improve survival chances. We would argue, though, that the small area at ages 90–
95 in 2000 is not the outcome of such a selection effect. Instead, we assume that it
is the outcome of random data fluctuations due to small numbers of persons getting
diagnosed. For example, 46 women at age 93 were diagnosed with breast cancer in
2000.
The corresponding estimates for colorectal cancer are depicted in Figs. 10.4
and 10.5 for women and men, respectively (pages 129 & 130). Both sexes feature
comparable estimates. The dynamics are somehow reminiscent of breast cancer




     






























































































































Fig. 10.4 Five year survival for colorectal cancer at ages 30–95 from 1973–2005. Left panel:
Probability to survive for 5 years after diagnosed with colorectal cancer (any cause). Middle panel:
Probability of not dying from colorectal cancer within 5 years after diagnosis. Right panel: Five
year survival of women diagnosed with colorectal cancer in relation to five year survival of women
in the general population (Data Source: SEER and Human Mortality Database)




   









































































































































Fig. 10.5 Five year survival for colorectal cancer at ages 30–95 from 1973–2005. Left panel:
Probability to survive for 5 years after diagnosed with colorectal cancer (any cause). Middle panel:
Probability of not dying from colorectal cancer within 5 years after diagnosis. Right panel: Five
year survival of men diagnosed with colorectal cancer in relation to five year survival of men in the
general population (Data Source: SEER and Human Mortality Database)
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albeit on a lower survival level: The chances to survive for another 5 years (left
panels) above age 80 tend to follow a horizontal trend over time. This could be
caused by at least two factors: Either there was no progress over time or that
competing causes at those advanced ages are more important. There was, indeed,
progress over time as shown by the panels in the middle of both figures. But despite
all this progress, relative survival is still at least 30% lower than in the general
population (right panels).
The dominance of shades of green in Figs. 10.6 and 10.7 illustrate that survival
chances are much worse for lung cancer than for breast or colorectal cancer. The
chances to survive for another 5 years after being diagnosed with cancer are less
than 30%. Even at very advanced ages, relative survival is very low. On average it
is about 80% lower in comparison to the general population.
Pancreatic cancer, as shown in Fig. 10.8 for women and men, belongs to the
cancer sites with the worst survival chances. Living for another 5 years after
diagnosis is extremely unlikely with a proportion of survivors of less than 10%.
It is therefore not surprising that relative survival is also very low.
The last cancer site we investigated was prostate cancer (see Fig. 10.9). In terms
of survival it can be found at the other side of the spectrum of pancreatic cancer.
The vertical, numerically increasing, contour lines in the panel for relative survival
provide evidence for a clear period effect: Relative survival became more common
at all ages at a pace that was faster than improvements in survival in the general
population. The most recent estimates show values of relative survival of more
than 95%.
Differences in survival do not only exist between cancer sites. An important
factor is also the stage when the cancer is diagnosed first. The data used in this
study provide stage information for3
• “in situ”—a noninvasive neoplasm
• “localized”—an invasive neoplasm confined entirely to the organ of origin
• “regional”—a neoplasm that can not only be found in the organ of origin
• “distant”—a neoplasm that has spread to parts of the body remote from the
primary tumor site.
We only present an example for colorectal cancer, contrasting the survival
chances of persons where a localized tumor was detected with those with a distant
malignant neoplasm. Figure 10.10 present the results for women; the corresponding
plots for males are contained in Fig. 10.11. Both six-panel plots provide clear
evidence that early detection of colorectal cancer is, literally, a matter of life
3Further details can be found in the field description of variable “SEER Historic Stage A” in the
SEER research data record description.





















































































































Fig. 10.6 Five year survival for lung cancer at ages 36–95 from 1973–2005. Left panel: Probabil-
ity to survive for 5 years after diagnosed with lung cancer (any cause). Middle panel: Probability of
not dying from lung cancer within 5 years after diagnosis. Right panel: Five year survival of women
diagnosed with lung cancer in relation to five year survival of women in the general population
(Data Source: SEER and Human Mortality Database)
























































































































Fig. 10.7 Five year survival for lung cancer at ages 36–95 from 1973–2005. Left panel: Probabil-
ity to survive for 5 years after diagnosed with lung cancer (any cause). Middle panel: Probability
of not dying from lung cancer within 5 years after diagnosis. Right panel: Five year survival of
men diagnosed with lung cancer in relation to five year survival of men in the general population
(Data Source: SEER and Human Mortality Database)



































































































































































































































































Fig. 10.8 Five year survival for pancreatic cancer at ages 50–90 from 1973–2005. Left column:
women; right panel: men. Upper panels: Probability to survive for 5 years after diagnosed with
pancreatic cancer (any cause). Middle panels: Probability of not dying from pancreatic cancer
within 5 years after diagnosis. Lower panels: Five year survival of women or men diagnosed with
pancreatic cancer in relation to five year survival of women or men in the general population (Data
Source: SEER and Human Mortality Database)
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Fig. 10.9 Five year survival for prostate cancer at ages 52–90 from 1973–2005. Upper left panel:
Probability to survive for 5 years after diagnosed with prostate cancer (any cause). Upper right
panel: Probability of not dying from prostate cancer within 5 years after diagnosis. Lower left
panel: Five year survival of men diagnosed with prostate cancer in relation to five year survival of
men in the general population (Data Source: SEER and Human Mortality Database)
























































































































































































































































































Fig. 10.10 Five year survival for colorectal cancer at ages 60–95 from 1973–2005 by stage. Upper
row: Stage 1, localized cancer. Lower row: Stage 4, distant cancer. Left panels: Probability to
survive for 5 years after diagnosed with colorectal cancer (any cause). Middle panels: Probability
of not dying from colorectal cancer within 5 years after diagnosis. Right panels: Five year survival
of women diagnosed with colorectal cancer in relation to five year survival of women in the general
population (Data Source: SEER and Human Mortality Database)











































































































































































































































































































Fig. 10.11 Five year survival for colorectal cancer at ages 60–89 from 1973–2005 by stage. Upper
row: Stage 1, localized cancer. Lower row: Stage 4, distant cancer. Left panels: Probability to
survive for 5 years after diagnosed with colorectal cancer (any cause). Middle panels: Probability
of not dying from colorectal cancer within 5 years after diagnosis. Right panels: Five year survival
of men diagnosed with colorectal cancer in relation to five year survival of men in the general
population (Data Source: SEER and Human Mortality Database)
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and death: Relative survival is about ten to 20% lower than in the general population
when being diagnosed at an early stage (upper three panels in each figure). This
excess mortality is pale beside cancer that has already metastasized when being
diagnosed (lower three panels in each figure): Only 10% as many people survive the
next 10 years as in the general population.
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The goal of this monograph was to show a variety of possibilities to visualize
mortality dynamics on the Lexis plane. While we provided examples of raw
and smoothed mortality surfaces, our focus was on visualizing rates of mortality
improvement (“ROMIs”), i.e., the derivative of age-specific death rates with respect
to time. We provided ROMI examples for national populations covered by the
Human Mortality Database as well as for selected causes of death in the United
States. These “ROMI-plots” were quite instructive to detect period and cohort
effects. We also illustrated how changes in age-specific mortality contribute to a
gain (or loss) in life expectancy. In Chap. 9 we decomposed seasonal data for causes
of death to investigate whether the seasonal pattern, measured via the amplitude and
the peak moment (“phase”), has changed over or age. The previous chapter dealt
with survival chances of persons who were diagnosed with cancer.
Despite the large number of figures, our list is obviously not exhaustive; here
we want to provide a few more two ideas how the Lexis diagram can be used to
illustrate not only mortality dynamics.
Figure 11.1 adapts our ROMI approach to fertility. The top panel contains a
surface map of age-specific fertility rates in the eastern part of Germany. Birth
counts and corresponding exposures by single year of age and calendar time
were downloaded from the Human Fertility Database (2017). The estimates were
(again) generated with Camarda’s R package for smoothing surfaces with P-splines
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Fig. 11.1 Age-specific fertility in eastern Germany from 1956 until 2013. Top panel: Smoothed
surface map. Bottom panel: Surface map of rates of fertility improvement (Data source: Human
Fertility Database)
(Camarda 2012, 2015). The lower panel shows rates of fertility improvement, where
improvement means an increase in fertility. Thus, it is the opposite definition of
mortality where a decline in mortality was interpreted as an improvement. It is
already apparent in the upper panel that fertility dropped considerably a few years
after reunification. In 1993 and 1994, the so-called total fertility rate dropped to
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0.78 children per woman. This development corresponds to the dark, almost black,
vertical area around 1990.1
The subsequent recovery of the total fertility rate can be traced back to a strong
cohort effect as illustrated by the red, orange, and yellow triangular area starting in
about 1995 at ages 25 and above. It is equally interesting that age-specific fertility
of younger women (aged about 20–24) has not gone back to pre-reunification levels
but continues to decrease. The figure also shows that a similar development of a
sudden decline and recovery was experienced already in during 1960s and 1970s.
The last example we want to provide is for the third main parameter in demogra-
phy: Migration. In Fig. 11.2 we depicted the smoothed age-profile of immigrations
of men in Sweden. We estimated for each year from 1968 to 2016 the relative
frequencies of each single age. The corresponding plot based on unsmoothed data
is included in the appendix in Fig. A.14. We selected this plot because it shows that
the age schedule of immigration movements is rather time-invariant—despite the
increase of immigrants in recent years coming to Sweden. Male migrants during
the past 50 years were typically 20 to 30 years old when they arrived in Sweden.
There was virtually not a single year, when more than 1% at a single age of men,
i.e., approximately the expected value of a uniform distribution over age, coming to
Sweden were older than 45 years.
Using the Lexis diagram is not restricted to depict dynamics of populations. In
principle any phenomenon that can be classified by age and calendar time could
be illustrated. One example could be unemployment. We would argue that a plot
created analogously to the ROMI-plots could easily reveal how labor market reforms
may affect various age-groups differently.
We also would like to point out that a plot in the Lexis diagram is not the answer
to any question related to population dynamics; for example, maps might be more
suitable for spatial analyses or circular plots for migration flows as popularized
among demographers by Abel and Sander (2014).
1The reader might be surprised that the dark gray areas start already in the late 1980s and may
attribute it to the impact of smoothing. Please note that fertility started to decline at several ages
already before re-unification in 1990. Thus, the gray areas that show up in the late 1980s can not
be traced back completely to the impact of smoothing. Please see Fig. A.13 in the appendix for the
corresponding surface maps based on unsmoothed age-specific fertility rates.
































Fig. 11.2 (Smoothed) Age-profile (relative frequencies) of immigrations of men to Sweden,
1968–2016 (Data source: Statistics Sweden)
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In the introductory chapter we wrote that the main reasons to visualize data
can be summarized to be exploration, confirmation, and presentation. We assume
that more exploratory analyses will be conducted in coming years using dynamic
graphics as their generation is nowadays greatly facilitated by platforms such as
node.js, for instance. Nevertheless, we remain confident that plots as the ones
contained in this monograph will continue to serve as important tools in all three
areas.
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Fig. A.13 Age-specific fertility in eastern Germany from 1956 until 2013. Top panel: Unsmoothed
surface map. Bottom panel: Surface map of rates of fertility improvement based on unsmoothed







































Fig. A.14 (Unsmoothed) Age-profile (relative frequencies) of immigrations of men to Sweden,
1968–2016 (Data source: Statistics Sweden)
Software: R package ROMIplot
A.1 Background, Installation and Requirements
All figures in this monograph have been created using R (R Development Core Team
2015), a free software environment for statistical computing and graphics. The first
author of this monograph has written an extension package for R to facilitate the
creation of plots of rates of mortality improvement for others (Rau and Riffe 2015).
The current version of the package includes code written by Tim Riffe to read data
from the Human Mortality Database.
The package is called ROMIplot and can be downloaded from any CRAN
mirror, the central repository of all R packages, in the canonical way:
install.packages("ROMIplot")
It needs to be downloaded only once but has to be activated whenever it is needed
in an R session via:
library(ROMIplot)
Apart from the base system and the packages utils, graphics, and
grDevices—which are all included in any standard distribution of R—package
ROMIplot has two dependencies, i.e., it requires two additional packages to
function properly:
• MortalitySmooth to smooth mortality data (Camarda 2015, 2012).
• RCurl is an interface to the libcurl library that enables accessing data on
the internet (Lang and the CRAN team 2015). Package ROMIplot uses it to
download data from the Human Mortality Database.
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A.2 Functions
A.2.1 readHMDformat()
The function readHMDformat() requires four input parameters.
• CNTRY: A character string denoting the country for which the data should be
downloaded. It is specified as an abbreviated name, which follows in most cases
the ISO 3166-1 alpha-3 standard. For instance data for Austria can be obtained
by setting CNTRY="AUT". There are exceptions if major territorial changes
occurred or if subpopulations are available. Examples are CNTRY="DEUTE"
for data from the (territory of the) former German Democratic Republic or
CNTRY="GBR_NIR" for data from Northern Ireland. An overview of all
possible values for CNTRY is given in Table A.1 on page 163.
• username: Obtaining data from the Human Mortality Database requires free
registration. This is the username to access the data. Typically, this is the
email address that was used to register supplied as a character string such as
username="my.name@my.email.com".
• password: Obtaining data from the Human Mortality Database requires free
registration. This is the username to access the data. Typically, this is a 10 digit
number supplied as a character string, such as password="1234567890".
• fixup: A Boolean value. If set to TRUE the obtained data are already “cleaned”.
For instance, age data from the Human Mortality Database do not include any-
more non-numeric values such as “110+”. The default setting of this parameter
is TRUE.
The function returns a list consisting of two data frames.
• @deaths: A data frame with deaths by single calendar year (Year) and single
age year (Age) for women (Female), men (Male) and both of them combined
(Total).
• @exposures: A data frame with exposure-to-risk estimates by single calendar
year (Year) and single age year (Age) for women (Female), men (Male) and
both of them combined (Total).
A.2.2 create.Lexis.matrix()
The function create.Lexis.matrix() requires six input parameters.
• HMD.dataset: A data frame in the format as obtained using the function
readHMDformat()
• Sex: A character string, set by default to Female to select data for women.
Other possible values are Male and Total
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Table A.1 Abbreviations (“CNTRY”) and their corresponding country names in the Human
Mortality Database
CNTRY Country CNTRY Country CNTRY Country
AUS Australia FRACNP France Civil. POL Poland
AUT Austria National Pop. PRT Portugal
BEL Belgium HUN Hungary RUS Russia
BGR Bulgaria IRL Ireland SVK Slovakia
BLR Belarus ISL Iceland SVN Slovenia
CAN Canada ISR Israel SWE Sweden
CHL Chile ITA Italy TWN Taiwan
CHE Switzerland JPN Japan UKR Ukraine
CZE Czech Republic LTU Lithuania GBR_NP United Kingdom
DEUTNP Germany LUX Luxembourg Total Pop.
National Pop. LVA Latvia GBRTENW Engl. & Wales
DEUTE Germany – East NLD Netherlands Total Pop.
DEUTW Germany – West NOR Norway GBRCENW Engl. & Wales
DNK Denmark NZL_NP New Zealand Civil. Pop.
ESP Spain National Pop. GBR_SCO Scotland
EST Estonia NZL_MA New Zealand GBR_NIR N. Ireland
FIN Finland Maori USA United States
FRATNP France Total NZL_NM New Zealand
National Pop. Non-Maori
• minage: An integer which denotes the youngest ages to be included, set by
default to 50.
• maxage: An integer which denotes the oldest ages to be included, set by default
to 100.
• minyear: An integer which denotes the earliest calendar year to be included,
set by default to 1950.
• maxyear: An integer which denotes the latest calendar year to be included, set
by default to 2011.
The function returns a matrix that contains the combined number of deaths or
exposures for a given combination of calendar year and age. Row names denote ages
from minage to maxage; column names denote calendar years from minyear to
maxyear.
A.2.3 ROMI.plot()
The function create.Lexis.matrix() requires up to four input parameters.
• Dx: A matrix of death counts, expected to be in the format as prepared by function
create.Lexis.matrix.
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• Nx: A matrix of exposure to risk estimates corresponding to argument Dx,
expected to be in the format as prepared by function create.Lexis.matrix.
• mx: A matrix of death rates. If death counts and their corresponding exposure
estimates are not available, it is possible to provide instead a matrix of death
rates. Please note that argument smooth requires death counts and exposure
estimates. Thus, if only death rates mx are available, they can only be used “raw”
or have to be already “smoothed”.
• smooth: A boolean value, set to TRUE by default. If set to TRUE, the data
are smoothed using P-Splines. Please note that this smoothing approach models
death counts as a Poisson process using exposure to risk estimates as a (log)
offset. Hence, smoothing can not be performed if only death rates are provided
(argument mx). P-Spline smoothing has been introduced by Eilers and Marx
(1996) and was extended to two dimensions for mortality by Currie et al. (2004).
We use the user-friendly implementation by Camarda (2012, 2015).
Based on the matrix of (smoothed) death rates, function ROMI.plot() esti-
mates a matrix of rates of mortality improvement, x;t, applying and re-arranging
the standard equation for continuous population growth. Since we estimate the rates
annually, t D 1:
mx;tC1 D mx;t e





In most applications the returned matrix is not the main interest of the researcher
but the plot that is produced as a side effect. Please note that we used the same color
scheme as in the present volume. But this is only a suggestion. Our package is free
software. Thus, anyone should feel invited to modify and possibly also improve our
package as only the most fundamental elements have been included in the current
version.
References
Abel, G. J., & Sander, N. (2014). Quantifying global international migration flows. Science,
343(6178), 1520–1522.
Andreev, K. F. (2002). Evolution of the Danish population from 1835 to 2000 (Odense Monographs
on Population Aging, Vol. 9), Odense: University Press of Southern Denmark.
Arriaga, E. E. (1984). Measuring and explaining the change in life expectancies. Demography,
21(1), 83–96.
Arthur, W. B., & Vaupel, J. W. (1984). Some general relationships in population dynamics.
Population Index, 50(2), 214–226.
Berkson, J., & Gage, R. P. (1952). Survival curve for cancer patients following treatment. Journal
of the American Statistical Association, 47(259), 501–515.
Camarda, C. G. (2008). Smoothing methods for the analysis of mortality development. PhD thesis,
Universidad Carlos III de Madrid.
Camarda, C. G. (2012). MortalitySmooth: An R package for smoothing Poisson counts with P-
splines. Journal of Statistical Software, 50(1), 1–24.
Camarda, C. G. (2015). Smoothing and forecasting Poisson counts with P-splines. http://CRAN.
R-project.org/package=MortalitySmooth, R package version 2.3.4.
Canudas-Romo, V. (2003). Decomposition methods in demography. PhD thesis, Rijksuniversiteit
Groningen, Groningen, NL.
Caselli, G., & Vallin, J. (2006). Frequency surfaces and isofrequency lines. In G. Caselli, J.
Vallin, & G. Wunsch (Eds.), Demography. Analysis and synthesis (Vol. I, Chap. 7, pp. 69–77).
Amsterdam: Elsevier.
Caselli, G., Vaupel, J. W., & Yashin, A. I. (1985). Mortality in Italy: Contours of a century of
evolution. Genus, 41(1–2), 39–55.
CDC/NCHS. (2015). Mortality in the United States, 2014. NCHS Data Brief, Number 229,
Dec 2015. Available online as Supplementary Material at: https://www.cdc.gov/nchs/data/
databriefs/db229_table.pdf#1.
Chambers, J. (2008). Software for data analysis. New York: Springer.
Cho, H., Howlader, N., Mariotto, A. B., & Cronin, K. A. (2011). Estimating relative survival for
cancer patients from the SEER program using expected rates based on Ederer I versus Ederer
II method. Tech. Rep. 2011-01, National Cancer Institute.
Christensen, K., Doblhammer, G., Rau, R., & Vaupel, J. (2009). Ageing populations: The
challenges ahead. The Lancet, 374(9696), 1196–1208.
Crimmins, E. M., Preston, S. H., & Cohen, B. (Eds.). (2011). Explaining divergent levels of
longevity in high-income countries. Washington, DC: The National Academies Press.
© The Author(s) 2018
R. Rau et al., Visualizing Mortality Dynamics in the Lexis Diagram,




Currie, I. D., Durban, M., & Eilers, P. H. (2004). Smoothing and forecasting mortality rates.
Statistical Modelling, 4, 279–298.
Deborah, S. (1998). The da Vinci of Data. The New York Times, 30 March 1998.
Delaporte, P. (1938). Évolution de la mortalité française depuis un siècle. Journal de la société de
statistique de Paris, 79, 181–206.
Delaporte, P. (1942). Évolution de la mortalité en Europe depuis l’origine des statisques. Journal
de la société de statistique de Paris, 83, 183–203.
Drefahl, S., Ahlbom, A., & Modig, K. (2014). Losing ground — Swedish life expectancy in a
comparative perspective. PLOS ONE, 9(2), e88357.
Ederer, F., Axtell, L. M., & Cutler, S. J. (1961). The relative survival rate: A statistical methodology
(Chap. 6, pp. 101–121). National Cancer Institute Monograph, National Cancer Institute.
Eilers, P. H. C., & Marx, B. D. (1996). Flexible Smoothing with B-splines and Penalties. Statistical
Science, 11(2), 89–102.
Eilers, P. H. C., Gampe, J., Marx, B. D., & Rau, R. (2008). Modulation models for seasonal
incidence tables. Statistics in Medicine, 27(17), 3430–3441.
EurowinterGroup. (1997). Cold exposure and winter mortality from ischaemic heart disease,
cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe.
Lancet, 349, 1341–1346.
EurowinterGroup. (2000). Winter mortality in relation to climate. International Journal of
Circumpolar Health, 59, 154–159.
Feinstein, C. A. (2002). Seasonality of deaths in the U.S. by age and cause. Demographic Research,
6, 469–486.
Few, S. (2014). Why do we visualize quantitative data? Available Online At: http://www.
perceptualedge.com/blog/?p=1897, Visual Business Intelligence. A blog by Stephen Few. Last
verification: 14 June 2017.
Friendly, M. (2008). A brief history of data visualization. In C. H. Chen, W. K. Härdle, & A. Unwin
(Eds.), Handbook of data visualization (Springer Handbooks of Computational Statistics,
Chap. I, pp. 15–56). Berlin/Heidelberg: Springer.
Galilei, G. (1613). Istoria e dimostrazioni intorno alle macchie solari. Rome.
Gambill, B. A., & Vaupel, J. W. (1985). The LEXIS program for creating shaded contour maps
of demographic surfaces. Tech. Rep. RR–85–94. International Institute for Applied Systems
Analysis (IIASA), Laxenburg, A.
Hippocrates. (400BC). On airs, waters, and places. Translated by Francis Adams. Available online
at: http://classics.mit.edu/Hippocrates/airwatpl.html.
Huynen, M. M., Martens, P., Schram, D., Weijenberg, M. P., & Kunst, A. E. (2001). The impact
of heat waves and cold spells on mortality rates in the Dutch population. Environmental Health
Perspectives, 109, 463–470.
Ihaka, R. (1998). R: Past and future history. Available online at https://cran.r-project.org/doc/html/
interface98-paper/paper.html.
Jacobsen, R., Keiding, N., & Lynge, E. (2002). Long term mortality trends behind low life
expectancy of Danish women. Journal of Epidemiology and Community Health, 56, 205–208.
Jacobsen, R., Von Euler, M., Osler, M., Lynge, E., & Keiding, N. (2004). Women’s death in
Scandinavia—What makes Denmark different? European Journal of Epidemiology, 19(2),
117–121.
Jacobsen, R., Keiding, N., & Lynge, E. (2006). Causes of death behind low life expectancy of
Danish women. Scandinavian Journal of Social Medicine, 34(4), 432–436.
Janssen, F., Nusselder, W. J., Looman, C., Mackenbach, J. P., & Kunst, A. E. (2003). Stagnation in
mortality decline among elders in the Netherlands. Gerontologist, 43(5), 722–734.
Jdanov, D. A., Jasilionis, D., Soroko, E. L., Rau, R., & Vaupel, J. W. (2008). Beyond the Kannisto-
Thatcher database on old age mortality: An assessment of data quality at advanced ages.
Working paper MPIDR Working Paper WP-20083-013, Max Planck Institute for Demographic
Research, Rostock, Germany.
Kannisto, V. (1994). Development of oldest-old mortality, 1950–1990: Evidence from 28 developed
countries (Monographs on Population Aging, Vol. 1). Odense: Odense University Press.
References 167
Kannisto, V., Lauritsen, J., Thatcher, A. R., & Vaupel, J. W. (1994). Reductions in mortality at
advanced ages: Several decades of evidence from 27 countries. Population and Development
Review, 20, 793–810.
Keyfitz, N. (1977). Applied mathematical demography. New York: John Wiley & Sons.
Kintner, H. J. (2004). The life table. In J. B. Siegel & D. A. Swanson (Eds.), The methods and
materials of demography (2nd ed., Chap. 13, pp. 301–340). San Diego: Elsevier.
Kunst, A., Looman, C., & Mackenbach, J. (1990). The decline in winter excess mortality in the
Netherlands. International Journal of Epidemiology, 20, 971–977.
Lang, D. T., & the CRAN team. (2015). RCurl: General Network (HTTP/FTP/. . . ) Client Interface
for R. http://CRAN.R-project.org/package=RCurl, R package version 1.95-4.7.
de Leeuw, J. (2005). On abandoning XLISP-STAT. Journal of Statistical Software, 13(7), 1–5.
Leon, D. A., Chenet, L., Shkolnikov, V. M., Zakharov, S., Shapiro, J., Rakhmanova, G., Vassin, S.,
& McKee, M. (1997). Huge variation in Russian mortality rates 1984–1994: Artefact, alcohol,
or what? The Lancet, 350(9075), 383–388. https://doi.org/10.1016/S0140-6736(97)03360-6,
http://www.sciencedirect.com/science/article/pii/S0140673697033606.
Lindahl-Jacobsen, R., Rau, R., Jeune, B., Canudas-Romo, V., Lenart, A., Christensen, K., &
Vaupel, J. W. (2016). Rise, stagnation, and rise of Danish women’s life expectancy. Proceedings
of the National Academy of Sciences, 113(15), 4015–4020. doi:10.1073/pnas.1602783113,
http://www.pnas.org/content/113/15/4015.abstract, http://www.pnas.org/content/113/15/4015.
full.pdf.
Luy, M. (2004). Mortality differences between Western and Eastern Germany before and after
Reunification. A macro and micro level analysis of developments and responsible factors.
Genus, 60(3/4), 99–141.
Mackenbach, J., Kunst, A., & Looman, C. (1992). Seasonal variation in mortality in the
Netherlands. Journal of Epidemiology and Community Health, 46, 261–265.
Marrero, O. (1983). The performance of several statistical tests for seasonality in monthly data.
Journal of Computational Statistics and Simulation, 17, 275–296.
Mathworks. (2017). Matlab. Available at www.mathworks.com.
Max Planck Institute for Demographic Research (Germany) and Vienna Institute of Demography
(Austria). (2017). Human fertility database. Available at http://www.humanfertility.org.
McDowall, M. (1981). Long term trends in seasonal mortality. Population Trends, 26, 16–19.
Meslé, F. (2004). Mortality in Central and Eastern Europe: Long-term trends and recent upturns.
Demographic Research Special Collection, 2, 45–70.
Meslé, F. (2006). Medical causes of death. In G. Caselli, J. Vallin, & G. Wunsch (Eds.),
Demography. Analysis and synthesis (Vol. II, Chap. 42, pp. 29–44). Amsterdam: Elsevier.
Meslé, F., & Vallin, J. (1996). Reconstructing long-term series of causes of death. Historical
Methods, 29, 72–87.
Meslé, F., & Vallin, J. (2006a). Diverging trends in female old-age mortality: The United States and
the Netherlands versus France and Japan. Population and Development Review, 32, 123–145.
Meslé, F., & Vallin, J. (2006b). The health transition: Trends and prospects. In G. Caselli, J. Vallin,
& G. Wunsch (Eds.), Demography. Analysis and synthesis (Vol. II, Chap. 57, pp. 247–259).
Amsterdam: Elsevier.
Moore, T. B., & Hurvitz, C. G. (2009). Cancers in childhood. In D. A. Casciato & M. C. Territo
(Eds.), Manual of clinical oncology (Chap. 18, p. 397). Philadelphia: Lippincott Williams &
Wilkins.
National Bureau of Economic Research. (1959–2015). Mortality data — Vital statistics NCHS’
multiple cause of death data, 1959–2015. http://www.nber.org/data/vital-statistics-mortality-
data-multiple-cause-of-death.html.
National Cancer Institute. (2017). NCI dictionary of cancer terms. Available Online at https://www.
cancer.gov/publications/dictionaries/cancer-terms.
National Center for Health Statistics. (1959–2015). Mortality multiple cause files. Available online
at https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm#Mortality_Multiple.
Pampel, F. C. (2001). Cigarette diffusion and sex differences in smoking. Journal of Health and
Social Behavior, 42, 388–404.
168 References
Parkin, D., & Hakulinen, T. (1991). Analysis of survival. In O. Jensen, D. Parkin, R. MacLennan,
C. Muir, & R. Skeet (Eds.), Cancer registration: Principles and methods (Chap. 12, pp. 159–
176). No. 95 in IARC Scientific Publication, International Agency for Research on Cancer
(IARC).
Pechholdová, M. (2009). Results and observations from the reconstruction of continuous time
series of mortality by cause of death: Case of West Germany, 1968–1997. Demographic
Research, 21, 535–568.
Peters, F. (2015). Deviating trends in Dutch life expectancy. PhD thesis, Erasmus University
Rotterdam, Rotterdam, NL.
Preston, S. H., Heuveline, P., & Guillot, M. (2001). Demography. Measuring and modeling
population processes. Oxford, UK: Blackwell Publishers.
Pullum, T. W. (1980). Separating age, period, and cohort effects in white US fertility, 1920–1970.
Social Science Research, 9(3), 225–244.
Quetelet, A. (1838). De l’influence des saisons sur la mortalité aux différens ages dans la Belgique.
M. Hayez, Bruxelles, B.
R Development Core Team. (2015). R: A language and environment for statistical computing.
R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org, ISBN:3-
900051-07-0.
Rau, R. (2007). Seasonality in human mortality. A demographic approach (Demographic research
monographs). Heidelberg: Springer.
Rau, R., & Doblhammer, G. (2003). Seasonal mortality in Denmark. The role of sex and age.
Demographic Research, 9, 197–222.
Rau, R., & Riffe, T. (2015). ROMIplot: Plots surfaces of rates of mortality improvement. R package
version 1.0.
Rau, R., Jasilionis, D., Soroko, E. L., & Vaupel, J. W. (2008). Continued reductions in mortality at
advanced ages. Population & Development Review, 34(4), 747–768.
van Rossum, G. (1995). Python reference manual. Tech. rep., CWI (Centre for Mathematics and
Computer Science), Amsterdam, The Netherlands.
Rutherford, M. J., Dickman, P. W., & Lambert, P. C. (2012). Comparison of methods for calculating
relative survival in population-based studies. Cancer Epidemiology, 36(1), 16–21.
Schumann, H., & Müller, W. (2000). Visualisierung. Grundlagen und allgemeine Methoden.
Berlin/Heidelberg: Springer.
Seretakis, D., Lagiou, P., Lipworth, L., Signorello, L. B., Rothman, K. J., & Trichopoulos, D.
(1997). Changing seasonality of mortality from coronary heart disease. Journal of the American
Medical Association, 278, 1012–1014.
Shkolnikov, V. M., Andreev, E. M., McKee, M., & Leon, D. A. (2013). Components and possible
determinants of decrease in Russian mortality in 2004–2010. Demographic Research, 28(32),
917–950.
Surveillance, Epidemiology, and End Results (SEER) Program. (2014). Research data (1973–
2011). Available online at www.seer.cancer.gov. National Cancer Institute, DCCPS, Surveil-
lance Research Program, released April 2014, based on the November 2013 submission.
Talbäck, M., & Dickman, P. W. (2011). Estimating expected survival probabilities for relative sur-
vival analysis—Exploring the impact of including cancer patient mortality in the calculations.
European Journal of Cancer, 47(17), 2626–2632.
Thatcher, R. A., Kannisto, V., & Vaupel, J. W. (1998). The force of mortality at ages 80 to 120
(Monographs on population aging, Vol. 3). Odense: Odense University Press.
Tufte, E. R. (2001). The visual display of quantitative data (2nd ed.). Cheshire: Graphics Press.
Tufte, E. R. (2003). The cognitive style of PowerPoint. Cheshire: Graphics Press.
Tukey, J. W. (1977). Exploratory data analysis. Reading, MA: Addison-Wesley.
University of California, Berkeley (USA), and Max Planck Institute for Demographic Research,
Rostock, (Germany). (2007). Methods protocol for the human mortality database. Available at
http://www.mortality.org/Public/Docs/MethodsProtocol.pdf.
References 169
University of California, Berkeley (USA), and Max Planck Institute for Demographic Research,
Rostock, (Germany). (2017). Human mortality database. Available at http://www.mortality.
org.
Van Den Berg, G. J. (1860). Befolknings statistik in: Underdaniga berattelse for dren 1856–1860,
ny folijd II, 3. Stockholm, Statistika Central-Byrans.
Vandeschrick, C. (2001). The Lexis diagram, a misnomer. Demographic Research, 4(3), 97–124.
doi:10.4054/DemRes.2001.4.3, http://www.demographic-research.org/volumes/vol4/3/.
Vaupel, J. W., Gambill, B. A., & Yashin, A. I. (1985a). Contour maps of population surfaces. Tech.
Rep. RR–85–47, International Institute for Applied Systems Analysis (IIASA), Laxenburg, A.
Vaupel, J. W., Gambill, B. A., & Yashin, A. I., Bernstein, A. J. (1985b). Contour maps of
demographic surfaces. Tech. Rep. RR–85–33, International Institute for Applied Systems
Analysis (IIASA), Laxenburg, A.
Vaupel, J. W., Gambill, B. A., & Yashin, A. I. (1987). Thousands of data at a glance: Shaded
contour maps of demographic surfaces. Tech. Rep. RR–87–16, International Institute for
Applied Systems Analysis (IIASA), Laxenburg, A.
Vaupel, J. W., Zhenglian, W., Andreev, K. F., & Yashin, A. I. (1997). Population data at a glance:
Shaded contour maps of demographic surfaces over age and time (Odense Monographs on
Population Aging, Vol. 4). Odense: University Press of Southern Denmark.
Wang, H., & Preston, S. H. (2009). Forecasting United States mortality using cohort
smoking histories. Proceedings of the National Academy of Sciences, 106(2), 393–398.
doi:10.1073/pnas.0811809106, http://www.pnas.org/content/106/2/393.abstract, http://www.
pnas.org/content/106/2/393.full.pdf.
Wilmoth, J. R. (2006). Age-period-cohort models in demography. In G. Caselli, J. Vallin, &
G. Wunsch (Eds.), Demography. Analysis and synthesis (Vol. I, Chap. 18, pp. 227–236).
Elsevier, Amsterdam.
Yen, C. J., Chao, C. L., Sung, F. C., Chen, W. J., Liau, C. S., & Lee, Y. T. (2000). Seasonal effects
on cardiovascular mortality in older patients. Age & Ageing, 29, 186–187.
